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ABSTRACT OF THE DISSERTATION

Association between Obesity, Depression, and Inflammation among Seventh-day
Adventists in the Biopsychosocial Religion and Health Study
by
Michael Paalani
Doctor of Public Health Candidate in Preventive Care
Loma Linda University, 2010
Serena Tonstad, Chair

The effects of obesity and depression on morbidity and mortality may be
mediated by inflammatory processes. Homeostasis within the immune system depends
on a balance of pro-inflammatory and anti-inflammatory cytokine molecules, so chronic
inflammatory diseases may result from cytokine dysregulation. The target population
consisted of 508 Seventh Day Adventists (SDAs) who participated in the
Biopsychosocial Religion and Health Study (BHRS), a sub-study of the Adventist Health
Study-2. The study was a cross-sectional analysis of the association between obesity,
depression, and inflammation after controlling for demographic, socioeconomic, health
behavioral, and health status variables among BHRS participants.
Obesity was assessed by body mass index (BMI) and waist circumference (WC)
measurements, while the Center for Epidemiological Studies Depression Scale 11-item
short form was used to measure depression. Enzyme linked immunosorbant assays were

m

utilized to measure the serum concentrations of c-reactive protein (CRP), interleukin-6
(IL-6), interleukin-10 (IL-10) and tumor necrosis factor-a (TNF-a). Statistical analysis
was accomplished by multiple linear regression using SPSS version 17. Obesity
measurements and depression scores served as predictor variables, while inflammatory
marker concentrations functioned as dependent variables in linear regression equations.
Control variables included age, gender, ethnicity (Blacks and Whites), education, degree
of difficulty meeting family expenses, exercise frequency, diet (vegetarian or non
vegetarian), and inflammatory conditions.
Results showed that CRP was positively associated with age, female gender, BMI,
WC, and non-vegetarian diet. IL-6 was positively associated with age, BMI, WC, and
Black ethnicity, while IL-10 was positively associated with exercise frequency after
controlling for all other covariates. In addition, depression scores were positively
associated with female gender, BMI, WC, increased difficulty meeting family expenses
in the last year, and the diagnosis of an inflammatory condition after controlling for all
other factors. However, depression scores were not associated with any of the
inflammatory markers based on the regression analysis.
In conclusion, the risk for inflammation varied according to age, gender,
ethnicity, and overall body mass among SDAs. Lifestyle factors such as exercise and
vegetarian diet were associated with reduced inflammation. Therefore, health behavior
variables may serve as important components of therapeutic lifestyle interventions and
should be studied among distinct sociodemographic populations.
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CHAPTER 1
INTRODUCTION
A. Statement of the Problem
The increase in obesity continues to be a significant public health problem in the
United States, where the prevalence has doubled among adults between 1980 and 2004
(Ogden et ah, 2006). Obesity is associated with an increased risk for chronic health
problems such as diabetes mellitus, cardiovascular disease, hypertension, and some
cancers (Blanck et ah, 2006; Haslam & James, 2005; Must et ah, 1999; Pi-Sunyer, 1999).
Moderate amounts of weight loss help to reduce the risk for many of these diseases, but
many studies of dietary and behavioral treatments have shown that maintaining weight
loss is difficult (Ogden, Yanovski, Carroll, & Flegal, 2007). The prevalence of
depression also increased significantly among US adults between 1992 and 2002
(Compton, Conway, Stinson, & Grant, 2006), often leading to severe physical and
psychological impairments, and increasing the risk of health complications including
coronary heart disease, myocardial infarction, heart failure, osteoporosis, and increased
mortality (J. Abramson, Berger, Krumholz, & Vaccarino, 2001; Robbins, Hirsch,
Whitmer, Cauley, & Harris, 2001; Schulz et ah, 2000).
Given the fact that both obesity and depression are common disorders, it is
possible that the two conditions may co-exist among many individuals. For instance, the
negative thoughts and attitudes characteristic of depression may contribute to weight
management problems due to low levels of self-efficacy (Markowitz, Friedman, & Arent,
2008) and obesity may contribute to a poor self-image and, hence, increased risk of
depression (O'Dea, 2006). Studies have demonstrated a positive association between
1

obesity and depression (McElroy et al., 2004; Rosmond, 2004), yet some discrepancies
exist in the literature which may be a result of variations in the study populations related
to age, gender, ethnicity, and degree of obesity (Greenman & Stern, 2007). Therefore,
the association between obesity and depression may depend on population specific
factors. McElroy et al (2004) have speculated that obesity and mood disorders (such as
depression) are separate but related disorders with distinct but overlapping
pathophysiologies. According to this model, obesity and depressive mood disorders are
both heterogeneous and complex illnesses that may share pathogenic and genetic factors.
There may be forms of these conditions that are pathogenically similar, and other forms
that are not related. For instance, typical or melancholic depression is often associated
with anorexia and decreased food intake, while atypical depression is primarily
characterized by increased appetite and weight gain (Dipietro, Anda, Williamson, &
Stunkard, 1992). This model may help to explain why obesity and depression may be
associated with one another under some conditions, but not others.
In addition to determining the relationship between obesity and depression, it is
important to understand the mechanisms by which these conditions function in order to
determine the effect of obesity and depression on overall health. For instance,
inflammation may result from an inability of the central nervous system and the immune
system to adapt to the physiological needs of the body for individuals with increased
body weight and depressive symptoms. Homeostasis can be disrupted by changes in the
levels of cytokines and other important inflammatory molecules. This may lead to
problems associated with well-being, affecting cognitive ability as well as metabolic and
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cardiovascular health which can influence human disability and life expectancy (Elenkov,
2008).
Inflammation has been associated with cardiovascular disease (CVD) which is the
main cause of death in western societies (Greaves & Channon, 2002). The main
underlying cause of CVD is atherosclerosis, which is a pathological process that begins in
the first decade of life and gives rise to fatty streak lesions within arteries. Growth of
atherosclerotic plaques can cause significant narrowing of the arterial lumen, leading to
chronic problems such as stroke, myocardial infarction, and angina (Libby, 2001). A
previous study by Ross (1993) found that no classic risk factor for atherosclerosis could
be determined in approximately 50% of coronary disease events among a normal, healthy
population. Yet in the last 15 years, a growing body of evidence supports the notion that
inflammation plays a pivotal role in the onset and progression of atherosclerosis (Doria,
Sherer, Meroni, & Shoenfeld, 2005; Libby, 2002).
Inflammation has also been shown to play an important role in insulin resistance,
a condition in which normal amounts of insulin are inadequate to effectively transport
glucose into the tissues of the body. In fact, there is epidemiological evidence that
inflammatory markers may predict the development of diabetes and glucose disorders
(Barzilay et al., 2001; Schmidt et al., 1999). Insulin resistance often serves as a
precursor to the onset of diabetes which is a major cause of morbidity and mortality in the
United States (Cowie et al., 2006). In addition, insulin resistance has been associated
with other metabolic problems such as glucose intolerance, hyperlipidemia and
hypertension, and consistent results have shown that cytokines are involved in the
pathophysiology of insulin resistance and atherosclerosis as well as the complications
3

associated with them (Black, 2003; Festa et al., 2000). Therefore, inflammation may
function as an important mediating factor that puts obese and depressed individuals at
increased risk for atherosclerosis and CVD as well as other metabolic problems
associated with insulin resistance.
B. Theoretical Framework
1. Effects of the HPA Axis and Depression
Lupien et al. (1998) found that a significant relationship exists between
depression and hypothalamic pituitary adrenal (HPA) axis dysregulation which can lead
to chronic elevations in cortisol levels in the body. Disruption of the HPA axis may
result from an inability to manage stress, and may lead to chronic inflammation
(Lozovaya & Miller, 2003). Miller, Stetler, Carney, Freedland, & Banks (2002)
determined that correlations exist between depression and increased levels of
inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6). It is
therefore possible that these proteins mediate the relationship by which depression
increases the risk for chronic health problems such as coronary heart disease events
(Carney, Freedland, Miller, & Jaffe, 2002). The increased inflammation from depression
may result from an elevated pro-inflammatory to anti-inflammatory cytokine ratio within
the immune system, in which there is a predominant Thl lymphocyte response. (Myint,
Leonard, Steinbusch, & Kim, 2005). The use of antidepressants has also been shown to
reduce pro-inflammation by decreasing the Thl/Th2 ratio, further supporting the idea that
cytokine secretion may be involved in the pathophysiology of depressive disorders
(Leonard, 2001).

4

2. Inflammatory Effects ofAdipose Tissue
Adipose tissue is considered to be an active organ that secretes molecules
regulating appetite, energy expenditure, insulin sensitivity, endocrine systems, bone
metabolism, and immunity (Fantuzzi, 2005). Obesity results from excessive caloric
intake that may lead to an inflammatory response due to the production and stimulation
of cytokine molecules from adipocytes (Musaad & Haynes, 2007). Specifically, obesity
has been associated with increased levels of pro-inflammatory proteins such as CRP,
TNF-cc, IL-1, IL-6, and IFN-y (I. Lemieux et ah, 2001; Mahadik, Deo, & Mehtalia,
2008). In addition, there is evidence that plasma TNF-a and IL-6 are further elevated in
patients with visceral obesity, and are potent stimulators of the HP A axis during
inflammation. Elevations in TNF-a and IL-6 can lead to increased concentrations of
glucocorticoids and catecholamines (Chrousos, 1995). Both glucocorticoids and
catecholamines are involved in the stress response to protect an individual from a
systemic increase in pro-inflammatory cytokine production by inducing a Th2 shift.
However, stimulation of the Thl axis may occur under conditions of extreme stress
which may activate macrophage molecules that will release various pro-inflammatory
cytokines. Many of these molecules are associated with increased risk for coronary heart
disease by increasing inflammation through a systemic response that is possibly mediated
at the genetic level. (Y. H. Lee et ah, 2005; Maachi et al., 2004). These changes in the
body may lead to physiological damage due to high concentrations of reactive oxygen
molecules and other harmful substances (Vincent, Innes, & Vincent, 2007). This
suggests that obesity may cause a shift in the cytokine profile toward a pro-oxidant state,
while a healthy weight may result in a more balanced oxidative state (Vincent & Taylor,
5

2006). However, the precise relationship between obesity and the Thl/Th2 axis has not
been fully characterized.
3. Effect of Obesity and Depression on Inflammation
Obesity and depression have both demonstrated independent low-grade
inflammatory effects. According to a recent study, obese individuals with high
depression levels had significantly elevated CRP concentrations in relationship to those
without depression or excess body weight (K.-H. Ladwig, Marten-Mittag, Lowel, Doring,
& Koenig, 2003). Another study found that adiposity was responsible for elevated levels
of inflammatory molecules among depressed individuals, indicating that excessive body
fat may affect the relationship between depression and inflammation (Miller, Freedland,
Carney, Stetler, & Banks, 2003). However, it is unclear whether obesity and depression
have an interactive effect on pro-inflammatory and anti-inflammatory cytokines
represented by the Thl and Th2 pathways, respectively. The association between various
inflammatory markers and the risk for CVD, diabetes, and other related health problems
has also not been completely determined. The theoretical model for the present study is
illustrated in Figure 1 below.
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Figure 1. Schematic representation of the interactions between obesity, depression, inflammation, and long
term health complications. Obesity and depression are associated with many chronic health problems, and
this relationship may be mediated by pro-inflammatory or anti-inflammatory molecules. Stimulatory
effects are represented by solid lines and inhibitory effects are represented by dashed lines. Confounding
variables include age, gender, ethnicity, education, degree of difficulty meeting family expenses, exercise,
diet, and diagnosis of an inflammatory condition.

4. Inflammation and Risk for Chronic Health Problems
Analyzing serum markers of atherosclerosis to determine the likelihood of
future cardiovascular problems has received greater attention in recent years. Many
factors have been associated with endothelial dysfunction as a result of damage to the cell
wall, leading to the development of atherosclerosis (Davignon & Ganz, 2004). For
instance, hypercholesterolemia, hypertension, diabetes mellitus, and cigarette smoking
are possible causes of endothelial dysfunction which is characterized by reduced
vasodilation and a shift toward a pro-inflammatory state to activate an immunological
cascade (Vapaatalo & Mervaala, 2001). The higher expression of Thl cells and proinflammatory cytokines (including INF-y, IL-1, IL-12, IL-15, IL-18, and TNF-a) found
in mouse models of atherosclerosis as well as in human plaques differ from the few cells
7

producing the Th2 cytokines such as IL-4 (Hansson & Libby, 2006). This represents an
imbalance in the Thl/Th2 cytokine axis and supports the idea that atherosclerosis is
mediated by Thl cells, which may partially explain the increased risk for coronary heart
disease events among individuals who suffer from obesity as well as depression (K. H.
Ladwig, Marten-Mittag, Lowel, Doring, & Wichmann, 2006)
When considering the role of cytokines in inflammation related to atherosclerosis
and CVD, it is important to distinguish between local inflammation (involved in the
activation of immune cells within the plaque microenvironment) and systemic
inflammation (involving the presence of acute phase proteins and circulating proinflammatory mediators). Locally produced pro-inflammatory mediators with
atherogenic activity include IFN-y, TNF-oc, IL-1, IL-8, IL-12, and IL-18. Systemic
markers of inflammation include IL-6 and CRP (Greaves & Channon, 2002).
Importantly, elevated CRP levels have been found in patients with myocardial infarction
and may be an indicator of coronary risk (Libby, 2002), while IL-6 levels have been
associated with future cardiovascular events among apparently healthy men (Ridker,
Rifai, Stampfer, & Hennekens, 2000). Therefore, analyzing different inflammatory
markers will help to determine their overall effects on the body as well as their degree of
association with heart disease. Finally, the proper method of treatment for cardiac
problems may depend on the degree of local and systemic inflammation based on the
extent of atherosclerotic damage and plaque buildup which may be neutralized through
anti-inflammatory mechanisms (Galkina & Ley, 2009).
Type 2 diabetes has traditionally been characterized as a metabolic disease.
However, inflammatory mediators also play an important role in the development of
8

insulin resistance and the risk for diabetes. For instance, both TNF-a and IL-6 have been
shown to reduce insulin sensitivity by attenuating the insulin signaling cascade which is
necessary for proper glucose uptake into insulin sensitive cells (Hotamisligil, Murray,
Choy, & Spiegelman, 1994). TNF-a also contributes to insulin resistance by inhibiting
the expression of genes which are essential for insulin signaling and adipocyte
differentiation (Ruan, Hacohen, Golub, Van Parijs, & Lodish, 2002). The pathogenesis
of type 2 diabetes may involve the pro-inflammatory endocrine function of adipose
tissue. In addition, hyperactivation of the HPA axis causes an increase in cortisol
concentration which can inhibit the effect of insulin and increase blood glucose levels,
possibly contributing to insulin resistance and the development of type 2 diabetes.
Depression prevalence is almost two fold higher among diabetics compared to
individuals without diabetes (Gavard, Lustman, & Clouse, 1993), while many individuals
who are obese are also at increased risk for diabetes (Resnick, Valsania, Halter, & Lin,
1998). Therefore, individuals suffering from obesity or depression may be at increased
risk for diabetes due to elevated cortisol and chronic inflammation.
In addition to cardiovascular and diabetic complications, autoimmune diseases
can also result from cytokine dysregulation. For instance, diseases such as rheumatoid
arthritis, multiple sclerosis, type 1 diabetes, Crohn’s disease and autoimmune thyroid
disease are associated with a pro-inflammatory response involving an activation of the
cellular immune system. On the other hand, allergic diseases such as asthma are
characterized by a Th2 response to stimulate the humoral immune response (Elenkov,
2008). Patients with autoimmune diseases normally show a higher incidence of affective
disorders and affective symptoms as well compared to patients with non-immune
9

disorders (Wolfe & Hawley, 1993). For these individuals, an increase in disease activity
has been associated with higher rates of depressive symptoms. In addition, obesity may
be linked to immune-mediated inflammatory diseases due to the effects of leptin and
other pro-inflammatory cytokines that are produced and secreted by adipose tissue (Lago,
Gomez, Lago, Gomez-Reino, & Gualillo, 2008). However, the precise impact of
depression and obesity on autoimmune diseases based on changes in inflammation
requires further analysis.
C. Cytokine Functions
1. Pro-inflammatory Cytokines
a. TNF-a In order to determine the effects of obesity and depression on
overall health problems, it is important to understand the function of some of the
inflammatory molecules that can disrupt normal homeostasis in our bodies. For instance,
one of the main functions of TNF-a is to promote necrosis in tumors after acute bacterial
infection. However, it is also involved in inflammation, metastasis, viral replication,
septic shock, fever, and the onset of autoimmune diseases (Locksley, Killeen, & Lenardo,
2001). It has also been determined that TNF-a can upregulate adhesion molecules on the
endothelium, stimulate fibroblast proliferation, recruit leukocytes from the circulation
into the synovial fluid, and promote angiogenesis and osteoclast differentiation to activate
osteoclasts and absorb bone. Many of these effects can lead to joint erosion and
inflammatory joint disease (Wong et ah, 2008). Finally, other factors such as IFN-a,
IFN-(3, IL-4, IL-6, and IL-10 have been shown to suppress the production of TNF- a as
part of a possible feedback mechanism (Juge-Aubry et al., 2005).
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TNF-a has also lead to reduced insulin sensitivity by its ability to downregulate facilitative glucose transporters in adipose tissue and may therefore play an
important role in the onset of obesity-linked insulin resistance (Hotamisligil, Arner, Caro,
Atkinson, & Spiegelman, 1995). Hypertriglyceridemia often results from elevated TNFa levels among animal and human subjects due to increased de novo fatty acid synthesis
in the liver and esterification to form triglycerides, induction of lipolysis in adipose
tissue, and decreased lipoprotein lipase activity (Warne, 2003). TNF-a is one of the most
important cytokines implicated in congestive heart failure as well. Myocardial stress and
volume overload can lead to high quantities of TNF-a production in the heart, which
have been shown to induce apoptosis in myocytes and endothelial cells. Finally, this
cytokine has been linked to vascular injury and may perpetuate atherosclerosis by acting
as a pro-inflammatory factor in ruptured plaques (Sarzi-Puttini, Atzeni, Doria, laccarino,
& Turiel, 2005).
b. IL-6 IL-6 is a cytokine with multiple effects on the body, such as bone
remodeling, neuroendocrine homeostasis, hematopoiesis, and inflammatory response
regulation. IL-6 is synthesized by many cell types, including T cells, macrophages, and
stromal cells (Heikkila, Ebrahim, & Lawlor, 2008). One of the main functions of this
cytokine is to provoke acute phase reactions which can lead to fever as well as production
of acute phase proteins (such as CRP) in the liver. Studies have found that IL-6 also has
anti-inflammatory functions by decreasing the levels of TNF-a and IFN-y and increasing
the concentration of IL-1 receptor antagonist during the course of an inflammatory
response (Mohamed-Ali et ah, 1997; Senn et ah, 2003). Therefore, IL-6 may play an
important role in balancing the pro-inflammatory/anti-inflammatory pathways. Like
11

TNF-a, IL-6 has been associated with increased lipolysis and decreased lipoprotein lipase
activity in human adipose tissue cultures, resulting in impaired lipid metabolism and an
increased production of triglycerides (Greenberg et al., 1992). IL-6 also causes partial
resistance to insulin dependent glucose uptake through down regulation of the insulin
receptor substrate and glucose transporter expression (Kern, Ranganathan, Li, Wood, &
Ranganathan, 2001). As one of the main pro-coagulant cytokines, IL-6 functions by
enhancing the synthesis of factors such as fibrinogen which is involved in the clotting
process as well (Willerson & Ridker, 2004). Finally, circulating IL-6 stimulates the HPA
axis which is often associated with central obesity, hypertension, and insulin resistance
(Pradhan, Manson, Rifai, During, & Ridker, 2001).
c. CRP CRP is an example of an acute phase protein that is normally
elevated when infections are present in the body. However, recent analysis shows that
cardiac risk is associated with higher levels of this protein, and that CRP is a strong
predictor of cardiac events even after adjusting for traditional risk factors (Yeh,
Anderson, Pasceri, & Willerson, 2001). CRP is responsible for inducing the expression
of cellular adhesion molecules that mediate adhesion of leukocytes to the vascular
endothelium, and CRP also induces monocytes to express specific glycoproteins involved
in the coagulation process which is a major factor in causing cardiovascular problems
(Nakagomi, Ben Freedman, & Geczy, 2000). CRP mediates LDL cholesterol uptake by
macrophages as well, and may be an important marker in the onset of systemic
inflammation which is involved in autoimmune diseases as well as atherosclerosis
(Zwaka, Hombach, & Torzewski, 2001).
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2. Anti-inflammatory Cytokine - IL-10
IL-10 is a cytokine produced by many types of cells such as monocytes,
macrophages, and lymphocytes. It has mainly anti-inflammatory properties by
suppressing the production of numerous pro-inflammatory cytokines (such as IL-1, IL-6,
and TNF-a) and stimulating anti-inflammatory molecules (including IL-1 receptor
antagonists and TNF-a receptors) (Esposito et ah, 2003). Because of its
immunosuppressive properties and its ability to stimulate B cell function which is
important in an adequate defense against intestinal parasites and neutralization of
bacterial toxins, it is referred to as a Th2 type cytokine (Asadullah, Sterry, & Volk,
2003). However, its biological activity may be more complex than this, and there is
growing evidence that IL-10 may have immuno-suppressive and immuno-stimulating
effects on adaptive immune cell mediators. IL-10 may be secreted by adipocytes, and
show higher levels among obese patients with increased fat tissue (Juge-Aubry et ah,
2005). In addition, both over-expression and under-expression of IL-10 have been
associated with different types of inflammatory problems, suggesting the need to
maintain adequate concentrations of this cytokine in the body. However, many of the
overall effects of IL-10 are still unclear. Finally, cytokine molecules can cause
significant changes in inflammation and the overall immune response. Therefore, due to
the positive association between obesity and depression with multiple chronic diseases,
the changes in CRP, IL-6, IL-10, and TNF-a levels as a result of obesity and depression
may provide an indication of an individual’s overall health risk.
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D. Purpose of the Study
The purpose of this study is to determine the mechanism by which obesity and
depression disrupt the normal physiological balance within the body. Therefore, the
association between obesity, scores of depression, and markers of inflammation will be
studied after controlling for demographic, socioeconomic, health behavioral, and health
status variables. The inflammatory analysis will compare systemic and local
inflammatory markers within the body and determine whether the balance of the Thl/Th2
axis is altered as a result of obesity and depression. Serum samples of CRT, IL-6, IL-10,
and TNF-a will be studied among Seventh-day Adventists (SDAs) who participated in
the Biopsychosocial Religion and Health Study (BRHS) to determine the role of these
factors on their risk for health problems. It may also be possible to identify segments of
the SDA population who are at lower risk for CVD and other inflammatory problems
based on their body mass measurements, depression scores, and inflammation level that
can be analyzed in future studies to better understand their higher condition of wellbeing.
E. Research Questions
1. Is obesity associated with depression?
2. Are obesity and depression each independently associated with markers of
inflammation (i.e., CRT, IL-6, IL-10, TNF-a)?
3. Do obesity and depression have a significant interactive effect on the
inflammatory marker concentrations?
4. Are there ethnic and gender specific differences in the inflammatory marker
concentrations?

14

F. Significance to Preventive Care
Preventive care specializes in promoting healthy lifestyles in order to reduce the
prevalence of chronic health problems among susceptible individuals. Since excessive
body weight and depression are associated with health complications, it is important to
determine which molecules become activated in the disease state. Inflammation has
been a major contributing factor toward the onset of atherosclerosis, insulin resistance,
and other conditions which can lead to greater risk of morbidity and mortality (Mahadik
et ah, 2008). Therefore, understanding which inflammatory markers are associated with
obesity and depression would allow us to better determine the patients’ level of health
risk and possibly find suitable methods of prevention. So promoting lifestyle changes
such as proper weight maintenance (through a balanced diet and incorporation of
adequate exercise), improved psychological well-being, and appropriate stress
management may prove to be therapeutic as anti-inflammatory methods of disease
prevention.

15

CHAPTER 2
REVIEW OF LITERATURE
A. Significance of Understanding the Relationship between Obesity, Depression, and
Inflammation
It is important to understand the relationship between depression and obesity as
well as their mechanism of action that can lead to long term health complications
(Markowitz et ah, 2008). Studies have shown that systemic inflammation may be the
factor leading to cardiovascular disease, diabetes, and other conditions among depressed
and obese individuals (Carney et ah, 2002; Leonard, 2007; Musaad & Haynes, 2007).
Therefore, this literature review will examine the relationship between obesity,
depression, and inflammation and their role in chronic health problems. The prevalence
and severity of obesity and depression will initially be explained, followed by an analysis
of the association between: (a) depression and inflammation, (b) obesity and
inflammation, (c) obesity and depression, and (d) obesity, depression, and inflammation.
This literature review will analyze the changes in both pro-inflammatory and anti
inflammatory molecules due to increased body weight and depression that can lead to
increased morbidity and a lower quality of life. The variable measurements utilized for
the present study and the implications for future analysis including the effect of diet and
exercise on inflammation will also be discussed.
B. Prevalence and Severity of Obesity
Obesity has become a prevalent condition and is a serious public health problem
in the United States (Hedley et ah, 2004; Ogden et ah, 2006). Data from the National
Health and Nutrition Examination Survey (NHANES) as well as the Behavioral Risk
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Factor Surveillance System (BRFSS) have shown that the obesity prevalence has
continued to increase within the last decade among adults in this country (Yun, Zhu,
Black, & Brownson, 2006). A recent analysis has indicated that 23.9% of US adults were
obese in 2005, and all states in the US showed an increased prevalence of obesity from
1995-2005 (Blanck et ah, 2006). The prevention of obesity is important because
significant increases in weight have been associated with increased risk for hypertension,
dyslipidemia, type 2 diabetes, coronary heart disease, stroke, and some cancers (Haslam
& James, 2005; Kopelman, 2000; Must et ah, 1999; Pi-Sunyer, 1999). Therefore, one of
the objectives of Healthy People 2010 is to reduce the prevalence of obesity in the United
States by 15% (Wang, Colditz, & Kuntz, 2007).
C. Prevalence and Severity of Depression
Depression is also a significant public health problem and one of the most serious
mental health problems in the United States. Elevated symptoms of depression can often
lead to impairments in physical and social functioning, and increase the risk of health
complications including coronary heart disease, myocardial infarction, low bone mineral
density, insulin resistance and other metabolic problems (J. Abramson et ah, 2001;
Anderson, Freedland, Clouse, & Dustman, 2001; Pohjasvaara, Vataja, Leppavuori, Kaste,
& Erkinjuntti, 2001; Robbins et ah, 2001; Schulz et ah, 2000). Like obesity, depression
contributes substantially to national morbidity and mortality, accounting for 8% of total
disability adjusted life years in the United States, and approximately 12% of all years
lived with disability worldwide in 2000 (Ustun, Ayuso-Mateos, Chatterji, Mathers, &
Murray, 2004). Therefore, individuals who suffer from both obesity and depression may
be at particularly high risk for health problems and reduced well-being.
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D. Association between Depression and Inflammation
Many studies have analyzed the relationship between depression and
inflammation and their association with coronary heart disease (CHD) events. For
instance, results from the Cardiovascular Health Study (CHS) and the Third National
Health and Nutrition Examination Survey (NHANES III) showed that depression
symptoms and a history of major depression were associated with elevated CRP levels
(Ford & Erlinger, 2004; Kop et ah, 2002). Even though both of these studies utilized
large samples of healthy individuals, the CHS was based on elderly individuals (65 years
or older) and the NHANES III participants were between the ages of 18 to 39. Therefore,
these effects may be typical for younger as well as older individuals. Depression was
also associated with increased levels of CRP, white blood cells, and fibrinogen based on
data from the ATTICA study (Panagiotakos et ah, 2004). Therefore, evidence suggests
that a correlation exists between depression and inflammation. However, because
surveys were utilized to measure the participant’s level of depression in these studies, the
results may have been affected by self-report bias. In addition, due to the cross-sectional
nature of these studies, the causal nature of association between depression and
inflammation is unclear, and the relationship between these risk factors and incident
CHD has not been fully characterized.
If depression results from an elevated inflammatory state, then depression
treatment would be beneficial in improving one’s quality of life but would not necessarily
reduce the risk of cardiovascular disease unless the inflammation is reduced as well. On
the other hand, if inflammation mediates the relationship by which depression increases
the risk for CHD events, then the benefits of inflammation treatment on CHD would not
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be effective over a prolonged period of time unless depression was treated as well
(Shimbo, Chaplin, Crossman, Haas, & Davidson, 2005). According to a prospective
case-control study, depression and various inflammatory markers (including CRP, IL-6,
and fibrinogen) significantly predicted CHD events after adjusting for various
cardiovascular risk factors, including tobacco and alcohol consumption, systolic blood
pressure, and total cholesterol (Empana et ah, 2005). In addition, the association between
depression and CHD events was not affected after evaluating depression and
inflammatory markers as covariates in the analysis. This suggests that the causal
pathways by which inflammation and depression increase the risk for CHD may occur
independently. However, the sample participants consisted only of healthy, European,
middle-aged men, making it difficult to generalize the results to other populations. Also,
depression and inflammation were measured at baseline only, so the changes in these
factors over time and the impact on CHD events could not be determined. Therefore,
additional research is needed to determine the causal relationship between depression,
inflammation, and CHD.
Inflammation and the associated secretion of pro-inflammatory cytokines may
also mediate the association of depression and diabetes. Elevations in pro-inflammatory
molecules such as IL-6 and TNF-ot have occurred among patients with depression and
with diabetes (Musselman, Betan, Larsen, & Phillips, 2003). In addition, recent
population based prospective studies reported that being depressed at baseline
significantly increases the risk of developing type 2 diabetes, and this relationship
appears to exist independently of other known diabetes risk factors, including obesity,
activity level, smoking, alcohol consumption and family history of diabetes (Everson19

Rose et al., 2004; Kawakami, Takatsuka, Shimizu, & Ishibashi, 1999). However, the
study by Kawakami, Takatsuka, Shimizu, & Ishibashi (1999) involved 3,066 male
participants from Japan, which limits the external validity of the information obtained
due to its gender and ethnic specificity. A study by Everson-Rose et al (2004) involved
2,662 female participants from the Study of Women’s Health Across the Nation (SWAN)
who were either Caucasian, African-American, Hispanic, Japanese, or Chinese. This
study found that depression was a significant predictor of diabetes among AfricanAmerican women only, which further illustrates that the effects of depression on diabetes
may be specific to gender and ethnic background. Finally, depression may serve as an
important risk factor in the development of type 2 diabetes among individuals at risk for
this disease, but the exact role of inflammatory cytokines in this process is still unclear.
There is evidence of an association between increased levels of pro-inflammatory
cytokines among individuals with major depression (Leonard, 2007). In addition, the
number of T helper cells, T memory cells, macrophages, and monocytes that act as a
source of cytokines are also increased in depressed individuals (Myint et ah, 2005).
There appears to be an imbalance between pro-inflammatory and anti-inflammatory
molecules within the cellular immune system of depressed individuals, in which the
cytokines from the Thl lymphocytes (pro-inflammatory) are predominant over the
cytokines from the Th2 lymphocytes (anti-inflammatory). It is possible that the
elevations in inflammatory molecules may result from a reduced threshold to stress. In
fact, it has been suggested that cytokine production contributes to a hyperactive
hypothalamic pituitary adrenal (HPA) axis which may lead to depression (Lozovaya &
Miller, 2003). However, depending on the ability of people to properly manage the stress
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in their lives, the effects of inflammation may only be found among certain depressed
individuals.
A shift in the pro-inflammatory/anti-inflammatory cytokine balance has been
demonstrated among patients suffering from major depression as well. A study by Huang
and Lee (2007) showed significantly higher levels of TNF-a in patients with major
depressive disorder compared to a control group. This inflammatory molecule may
therefore play a very important role in the psychopathology of major depression. TNF-a
levels have also been elevated in other clinical conditions such as multiple sclerosis and
Alzheimer’s disease, suggesting a possible role in neuronal dysfunction (Sheng, Boop,
Mrak, & Griffin, 1994). In addition, a higher pro-inflammatory/anti-inflammatory
cytokine ratio (IL-l/IL-10) was found among patients with melancholic depression than
in patients with non-melancholic features (T. L. Huang & Lee, 2007). This suggests that
melancholic and non-melancholic depression may have different immune patterns, but
future studies analyzing the relationship between cytokine levels, depression subtypes,
and the interactions between the HPA axis and immune system are still needed.
Similar changes in the cytokine balance has been demonstrated in other studies,
including an increase in the IFN-y/IL-4 ratio among patients with major depression
(Myint et ah, 2005). The ratio was significantly reduced following antidepressant
treatments, which indicates that the balance in the Thl and Th2 cytokine ratio plays an
important role in the pathophysiology of depression. However, different medications
were used to treat different groups of patients suffering from depression in this study, so
the precise mechanism of action on cytokine levels based on the treatment would be
difficult to determine. Another study found that major depression was associated with
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higher levels of IL-4 and IL-13 (Th2 cytokines) and lower levels of IL-2 and IFN-y (Thl
cytokines) that may have been due to the effects of increased cortisol in the body (Pavon
et ah, 2006). Yet this study consisted of only a small population of patients exclusively
of Mexican ethnicity (n=66), so further studies will be needed in this area. Specifically,
the causal relationship between depression and specific inflammatory markers should be
examined through longitudinal analysis.
E. Association between Obesity and Inflammation
Studies have found that obesity causes increases in circulating concentrations of
many pro-inflammatory, acute phase proteins. For instance, Lemieux et al (2001)
determined that CRP concentrations were significantly higher among obese individuals
than overweight or normal weight individuals. In addition, the correlation between CRP
concentrations and indices of body fatness and abdominal adipose tissue accumulation
were analyzed as well. This included BMI, fat mass, waist circumference, and visceral
and subcutaneous adipose tissue content. Although all these variables were significantly
correlated with CRP concentration, total body fat mass showed the highest correlation.
This study was very thorough by using several anthropometric measurements to assess
the participant’s fat content. ITowever, because the study consisted of a small sample
(n=159) of male subjects from Canada, these effects may be gender or population
specific. A more recent study also found a significant correlation between CRP
concentration and obesity parameters such as BMI and body fat percentage (Mahadik et
ah, 2008). This provides further evidence of a link between adipose tissue and
inflammation, despite the fact that the study consisted of a small sample (n=134) of Asian
Indian subjects which may limit external validity. Nevertheless, the finding of the same
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relationship in two very different populations (Asian Indians and male Canadians) lends
credence to the idea that the association may exist generally.
Similar results regarding obesity and inflammation were found in a large scale
study (n=3042) of participants from Greece, in which there were significantly higher
levels of CRP, TNF-a, IL-6, and white blood cells in subjects who were obese with a
central body fat distribution (based on waist-to-hip ratio measurements) compared to
normal weight participants with a normal body fat distribution. The inflammatory
molecules were significantly correlated with BMI and waist-to-hip ratio measurements
for male and female subjects as well, even after controlling for variables such as age,
smoking, physical activity, dietary habits, blood pressure, and lipid levels (Panagiotakos,
Pitsavos, Yannakoulia, Chrysohoou, & Stefanadis, 2005). Finally, despite the strong
evidence for obesity induced inflammation among various sample populations, the cross
sectional design of these studies limit the conclusions that can be drawn regarding the
causal relationship between obesity and inflammation.
Obesity is considered to be a state of chronic inflammation, in which adipose
tissue is an active endocrine organ as well as a storage depot for lipid energy. Expansion
of the adipose tissue depot in obese individuals has been associated with increased levels
of pro-inflammatory cytokines (such as TNF-a, IL-6, and CRP) that has been correlated
with type 2 diabetes as well as cardiovascular complications such as coronary artery
disease, myocardial infarction, stroke, thrombosis, and peripheral arterial disease (Kopp
et ah, 2003; Saito, Yonemasu, & Inami, 2003; Weyer et ah, 2002). There is a great
overlap in the prevalence of obesity, type 2 diabetes, and CVD in western society, and it
has become apparent that people with obesity are more prone to type 2 diabetes and other
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problems based on metabolic abnormalities that serve as major risk factors for CVD. For
instance, Saito et al (2003) found a strong association between circulating levels of CRP
and CVD risk factors such as smoking, obesity, high blood pressure and dyslipidemia,
but the study was a cross-sectional analysis which made it difficult to determine the
causal relationship between the variables. In addition, elevated CRP and IL-6 levels in
obese patients were found to significantly predict the development of type 2 diabetes in a
prospective case-control study by Pradhan et al (2001), but the analysis was based on
data from females participants only and was therefore gender specific. Nevertheless, the
results of these studies suggest that the pathophysiology of many of the comorbidities
associated with obesity may involve pro- inflammatory cytokine production.
In addition to stimulating the production of pro-inflammatory cytokines, obesity
may lead to an increased concentration of anti-inflammatory cytokines as well. For
instance, it was determined that circulating levels of IL-10 were higher among obese
women than non-obese women between the ages of 22 and 44 years old (Esposito et al.,
2003). However, the results provided were gender specific since males were not assessed
in the study. A more recent study showed that a significantly higher quantity of IL-10
was secreted by white adipose tissue from a small sample of obese patients compared to
normal weight patients (Juge-Aubry et al., 2005), although an analysis using a larger
sample size may be necessary to validate these results. Manigrasso et al (2005) found
that women suffering from android obesity were found to have a significantly lower
concentration of IL-10 compared to non-obese women. This suggests that the presence
of excess body fat in the abdominal region may explain the lower amount of IL-10
among this study population. However, it is unclear if the same effects are present
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among men. It has been well characterized that IL-10 is a major inhibitor of proinflammatory cytokines and has a protective role in atherosclerotic lesion formation and
stability (Endo et ah, 1996; Oslund et ah, 1999). Therefore, it is possible that adipose
tissue secretes pro-inflammatory as well as anti-inflammatory cytokines into the general
circulation that may alter the balance of the Thl/Th2 axis. However, the exact
pathophysiological process that contributes to the pro-inflammatory or anti-inflammatory
state is currently unknown.
Inflammation does not appear to be an initial cause of obesity. Rather, obesity
results from positive energy balance that can lead to inflammation due to effects of
cytokines present within fat cells (Musaad & Haynes, 2007). Many of the molecules
produced by adipocytes (known as adipocytokines) are associated with increased
cardiovascular or diabetes risk by either increasing the expression of inflammatory genes
or inducing systemic inflammation (Y. H. Lee et ah, 2005; Maachi et ah, 2004). In
addition to increased CRP concentrations, abnormal fat accumulation has also been
associated with other types of inflammatory changes such as the recruitment of
macrophages and activation of endothelial cells which can promote vascular disease
(Weisberg et ah, 2003). These changes in the body can ultimately lead to oxidative stress
due to high concentrations of free radicals and reactive oxygen species in the body.
Finally, inflammation and oxidative stress due to obesity is a systematic problem that
should be corrected by improving antioxidant defenses through exercise, dietary
modification, or a combination of both (Vincent & Taylor, 2006).
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F. Association between Obesity and Depression
According to current research, an association between obesity and depression
does appear to exist (Markowitz et ah, 2008). However, it has been difficult to generalize
the relationship between these two disorders because of the heterogeneity of the obese
population as well as methodological limitations of subject selection and measurement
(Friedman & Brownell, 1995). Most of the research in this area has focused on
comparing the depression level between obese and non-obese individuals based on
measures of psychological functioning, and the investigators have relied predominantly
on cross-sectional data to determine the association between obesity and depression
among different sample populations (Faith, Matz, & Jorge, 2002).
A study based on 2482 subjects from the 1995 Nova Scotia Health Survey
examined the relationship between body mass index and depression assessed with the
Center for Epidemiologic Studies Depression scale. The study showed that a higher BMI
was significantly associated with an increased risk for depression, with obese individuals
having a 41% increased odds of being depressed (Johnston, Johnson, McLeod, &
Johnston, 2004). Another study that analyzed a cohort of 1040 Swedish men found that
self-reported BMI was associated with increased depression symptoms on a self-report
questionnaire. Despite the large sample size, this study was limited by the use of selfreport assessments for these two factors which may have biased the data (Rosmond,
Lapidus, Marin, & Bjorntoip, 1996).
Based on data from the 2001 Behavioral Risk Factor Surveillance Survey
(BRFSS), a sample of 44,800 nationally representative respondents were studied to
determine the association between depressed mood and BMI. The results showed that
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obesity was associated with an increased likelihood for depressive mood among young
women, particularly who were Hispanic. Therefore, the relationship between depressive
mood and obesity seemed to be dependent on gender, age and ethnicity. However,
because this was a self-report telephone survey, the variables studied may have been
susceptible to measurement error. Individuals without telephones would also not be
eligible for this study, so the results do not reflect those from a low socioeconomic status.
Finally, these cross-sectional studies suggest a possible relationship between obesity and
depression, but the association between these variables is still not conclusive.
Longitudinal studies have found that obesity may predict later onset of depression
in adults. For instance, Roberts, Kaplan, Shema, and Strawbridge (2000) analyzed data
from a sample of 2730 middle-aged and older adults from Alameda County, and
determined that obesity at baseline was found to predict depression one year later (91%
increased odds of depression for obese individuals) after controlling for demographic and
psychosocial variables. In a 2002 study by the same research group, it was reported that
obesity at baseline also predicted depression five years later among the same participant
sample when controlling for depression at baseline, but that depression did not predict
obesity prospectively when controlling for obesity at baseline (Roberts, Strawbridge,
Deleger, & Kaplan, 2002). These longitudinal studies contained large sample sizes,
included diagnostic assessment of depression, and sufficiently controlled for baseline
variables, indicating that the results are based on strong methodological design.
There is evidence to suggest that some factors may cause certain obese
individuals to be at greater likelihood for developing depression. For instance, research
has shown that severe obesity puts individuals at greater risk for depression. According
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to the Third National Health and Nutrition Examination Survey (NHANES III), the most
severely obese individuals (BMI > 40) were at a significantly higher risk for depression
than those with a BMI between 30 and 34.9 (Onyike, Crum, Lee, Lyketsos, & Eaton,
2003). In addition, female gender may also be a potential risk factor for depression
among obese individuals. Data from NHANES-I showed that there was no significant
relationship between obesity status and depression among 1237 men, but obesity was
associated with increased depression among 1616 women (Istvan, Zavela, & Weidner,
1992). Low socioeconomic status is another risk factor that has been associated with
obesity and depression, suggesting that it may play a role in co-morbid depression and
obesity (Everson, Maty, Lynch, & Kaplan, 2002). Therefore, the risk for depression
among obese individuals may be increased by severe obesity, female gender, and low
socioeconomic status.
Studies have also examined the risk factors and causal mechanisms leading to
obesity among depressed individuals. One study compared a sample of children with
major depression disorder (MDD) to a control group and found that the group of children
with MDD at baseline had significantly higher BMI values compared to the control group
after being assessed 10 to 15 years later. This indicates that higher depression levels at
baseline may have lead to the elevated BMI in adulthood (Pine, Goldstein, Wolk, &
Weissman, 2001). Another longitudinal study involved a large sample of adolescents
who completed in home interviews for the National Longitudinal Study of Adolescent
Health, and were assessed for depression and BMI at baseline and one year later. It was
determined that baseline depressive symptoms independently predicted obesity at follow
up for those participants who were not obese at baseline, even after controlling for
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smoking, self-esteem, socioeconomic status, and physical activity (Goodman &
Whitaker, 2002). Finally, a study on a cohort of adolescent girls from New Zealand
found that depression at baseline lead to more than a twofold increased risk for obesity in
adulthood when compared to their non-depressed peers (Richardson et ah, 2003). These
results suggest that adolescent depression causes an increased risk for obesity later in life.
However, a study on the effect of depression on obesity in middle and late adulthood
found no significant change (Roberts, Deleger, Strawbridge, & Kaplan, 2003).
A recent cross sectional study analyzed the association between body mass index
and depression (based on a Mental Health Inventory) among a large sample of males and
females aged 18 to 90 years old from the Netherlands (n=43,534). The results showed
that there was a U-shaped association between BMI categories and depression, in which
the obese and underweight categories had higher levels of depression compared to the
normal and overweight groups (de Wit, van Straten, van Herten, Penninx, & Cuijpers,
2009). This suggests that depression may be associated with a positive as well as a
negative calorie balance that lead to changes in body weight. Other factors may therefore
affect the relationship between depression and body weight. However, because the BMI
values were based on self-reported height and weight measurements, the validity of the
results may have been compromised. The causal relationship between BMI and
depression could not be determined as well because the study was an observational
analysis.
The hypothalamic-pituitary-adrenal (HPA) axis is a biological pathway involving
increased stress reactivity with hormonal changes, and could promote weight gain among
individuals who are depressed. Activation of the HPA axis can lead to elevated levels of
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cortisol which has been found to promote weight gain and contribute to abdominal
obesity (Stunkard, Faith, & Allison, 2003). Research has also shown that failing to
regulate the HPA axis can elevate the risk for depression and increase susceptibility to
atherosclerosis and coronary heart disease (Carney et ah, 2002; Holsboer, 2000).
Therefore, this pathway may be an important neuro-endocrine link between depression
and the development of obesity, and could affect psychosocial factors such as binge
eating, poor adherence to weight loss programs, and reduced self-efficacy and social
support which are potential mediators of the obesity-depression relationship (Markowitz
et ah, 2008).
Obesity may play an important role in causing depression as well as other
psychological problems. Depression may also lead to obesity and increased weight gain
for many individuals. This bidirectional relationship between depression and obesity
may be affected by lifestyle factors that can influence the stress response as well. For
instance, physical activity may reduce depression and body weight due to its anti
inflammatory and calorie-burning effects in order to effectively cope with chronic stress
(Pereira et ah, 2007). However, sedentary behavior may promote the opposite effect, and
should be considered when assessing one’s physical and mental health.
G. Association between Obesity, Depression, and Inflammation
Recently, it has been suggested that increased inflammatory responses in
depressed individuals may at least partially depend on obesity. For instance, one study
compared a group of depressed and non-depressed subjects to determine the differential
expression of inflammatory markers implicated in CHD, and found that the former group
exhibited significantly higher levels of CRP and IL-6 compared to the latter group. An
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analysis of possible mediating factors contributing to this association also showed that the
depressed individuals had higher BMI values than the non-depressed subjects, and that
adjusting for BMI attenuated the group differences in CRP and IL-6. The results also
showed that there was a synergistic association between depression and obesity, in which
subjects with depression and high BMI (>30 km/m2) exhibited significantly higher CRP
levels compared to subjects who were either depressed or had a high BMI (Miller, Stetler,
Carney, Freedland, & Banks, 2002). Based on this evidence, the researchers argued that
depressed individuals may have accumulated excess weight over time as a result of
sedentary behavior. As this occurred, increased levels of IL-6 and CRP may have been
released by adipose tissue. Unfortunately, the cross-sectional design of this study makes
it impossible to determine the direction of causality between the variables.
Other studies using similar methodology have also found a significant association
between CRP concentrations and depression, in which the effect disappeared after
adjusting for body mass index (Douglas, Taylor, & O'Malley, 2004; Kop et ah, 2002). A
more recent study also showed that an increase in body weight (based on BMI and waist
circumference measurements) mediated the association between depression and CRP
levels among a large sample of elderly men and women (n=3609) from the English
Longitudinal Study of Aging. However, because inflammatory marker levels were not
measured at baseline, the longitudinal relationship between depression and inflammation
could not be determined (Hamer, Molloy, de Oliveira, & Demakakos, 2009). Therefore,
prospective analysis that measures obesity, depression, and inflammation at multiple time
points will be necessary to further understand the relationship between these variables.
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In another study, the investigators examined the relationship between depression,
obesity, and inflammatory molecules by the use of structural equation modeling (SEM) to
examine the validity of competing models specifying different patterns of association
between these variables. For the sample population, a group of depressed subjects were
compared to a control group with no psychiatric illness who were matched on a case by
case basis with respect to age, gender, and ethnicity. Based on SEM analysis, the joint
pathway model fit the data significantly better than any other model that was evaluated.
This model is consistent with the hypothesis that depression promotes weight
accumulation which can stimulate an inflammatory response, by inducing the expression
of leptin as well as releasing inflammatory molecules from adipose tissue (Miller et ah,
2003). These results identified adiposity and leptin as potential mediating pathways
linking depression with inflammation. Elowever, further research will be required to
validate this proposed mechanism.
A German study of 3204 male subjects examined whether depressive mood
modifies the relationship between obesity and serum concentrations of CRP in a nonclinical population. It was determined that there was a significantly increased
concentration of CRP among an obese sample of males with high levels of depression
compared to the non-obese group with low levels of depression. More importantly, there
was a significant interactive effect (based on the beta coefficient value corresponding to
the obesity x depression product) of body mass index and depressive symptoms on CRP
concentration among this sample population. Multivariate analysis further demonstrated
that depression significantly contributed to elevated levels of CRP in obese men after
controlling for confounders such as age, high blood pressure, smoking, physical
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inactivity, low social class, and alcohol intake (K. H. Ladwig, Marten-Mittag, Lowel,
Doring, & Koenig, 2003). This synergistic effect of obesity and depressive mood on
chronic inflammation may play an important role in determining a person’s risk for
cardiovascular and metabolic problems. However, further studies are needed to
determine if an interactive effect involving obesity and depression affects additional
markers of inflammation among other population groups that include males as well as
females.
A more recent study analyzed the relationship between symptoms of depression
and CRP concentration among a sample of 493 obese patients presenting for bariatric
surgery after controlling for identified determinants of CRP levels. Based on linear
regression analysis, it was determined that five independent factors were associated with
increased CRP. In order of strength of association, the factors were higher BMI, female
gender, estrogen therapy, higher depression, and insulin resistance (Dixon et ah, 2008).
The results also showed that progressively higher depression levels (based on scores from
the Beck Depression Inventory) and mean BMI values were correlated with higher
concentrations of CRP, indicating that the degree of obesity and the severity of
depressive symptoms were independently and incrementally associated with this acute
phase protein. These studies provide strong evidence for a positive association between
obesity, depression and inflammation, although the cytokines involved in the immune
response are still unclear.
H. Effect of Diet and Exercise on Inflammation
Lifestyle factors can affect inflammation as well. For instance, many studies have
shown that increased levels of physical activity have been associated with lower CRP
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concentrations (J. L. Abramson & Vaccarino, 2002; Geffken et al, 2001; Wannamethee
et al., 2002), but they are predominantly based on cross-sectional analysis such as the
Cardiovascular Health Study which found that CRP levels decreased in a dose-response
manner with increasing energy expenditure (Geffken et al., 2001). The results from
Health, Aging, and Body Composition Study showed that individuals who accumulated
at least 180 minutes of exercise per week had lower CRP levels compared to physically
inactive individuals after controlling for age, gender, and ethnicity (Colbert et al., 2004).
Analysis based on frequency of activity have reported that physical activity performed
only 1 time per week have been associated with lower CRP levels compared with
sedentary individuals, and more frequent activity leads to additional reduction in CRP
levels (Albert, Glynn, & Ridker, 2004; Colbert et al., 2004). However, the data from
these investigations were based on self-reported physical activity and are therefore
subject to self-report bias. Some longitudinal studies have been performed as well,
including a recent study which found that a 6 month aerobic exercise training program (at
a frequency of 4 times per week for 45-60 minutes per session) significantly reduced
CRP levels but increased IL-10 levels among 60 overweight individuals with type 2
diabetes (Kadoglou et al., 2007). Similarly, Stewart et al (2007) found that a 12 week
training program consisting of aerobic activity (at a frequency of 3 times per week for 20
minutes per session) and resistance exercises (2 sets of 8 repetitions at a frequency of 3
times per week) decreased CRP concentrations but did not affect IL-6 or TNF-a levels
among 70 healthy participants. Exercise may therefore reduce CRP levels and provide
anti-inflammatory benefits for both healthy and diseased populations, but the overall
inflammatory mechanism involved is not fully known.
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A number of well-controlled cross sectional studies have examined the
relationship between dietary factors and inflammatory markers. A nutritional analysis of
732 healthy women from the Nurses Health Study showed that a prudent dietary pattern
consisting of a high intake of fruits, vegetables, legumes, fish, poultry, and whole grains
was inversely associated with CRP levels. On the other hand, a western pattern
characterized by a higher intake of red and processed meats, sweets, and refined grains
was directly associated with increased CRP and IL-6 levels after controlling for potential
confounding variables (Lopez-Garcia et al., 2004). Dietary assessments of 5089 men and
women from the Multi-Ethnic Study of Atherosclerosis showed that a nutritional pattern
consisting of fats and processed meats was positively associated with CRP while a diet
made up predominantly of whole grains, fruits, nuts, and green leafy vegetables was
inversely associated with CRP and IL-6 levels (Nettleton et al., 2006). Furthermore, 30
long term vegetarians who consumed no meat or fish were found to have significantly
lower CRP concentrations when compared with 30 age and gender matched omnivores
(Szeto, Kwok, & Benzie, 2004). Dietary components appear to have a direct influence on
CRP and IL-6 levels, but their effects on other cytokines have not been determined and
require further research.
I. Variable Measurements Utilized for the Present Study
1. Center for Epidemiological Studies Depression (CESD) Scale
The CESD scale is a useful tool for measuring depression among various
populations. However, the 11 item short form of the CESD also provides a high degree of
reliability in analyzing four symptom dimensions (depressed affect, positive affect,
somatic complaints, and interpersonal problems) that are assessed by the original CESD
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as well. In addition, very little information and precision is sacrificed when shorter forms
are utilized as they have demonstrated high consistency and reliability. The 11 item short
form can also be administered in less than half the time needed for the original CESD.
This can help to lower costs in studies that utilize large surveys, provide elderly
participants with a simpler and more convenient response format, and reduce the
emotional stress burden that the original CESD may place on them (Kohout, Berkman,
Evans, & Cornoni-Huntley, 1993).
2. Body Mass Index (BMI) and Waist Circumference (WC)
Body Mass Index is a standardized method to determine an individual’s
height adjusted weight. Due to its ease of measurement and calculation, the BMI is one
of the most widely used diagnostic tools to identify weight problems within a population,
regardless of whether individuals are underweight (less than 18.5 kg/m2), overweight (25
-29.9 kg/m ), or obese (greater than 30 kg/m ). However, in order to determine the
amount of abdominal fat present among the study population, the waist circumference is
often measured as well. Waist circumference is highly correlated with visceral fat which
is associated with negative health consequences including hypertension, type 2 diabetes.
hyperlipidemia, and coronary artery disease (Bergman et ah, 2007). Therefore, the waist
circumference associated with increased obesity-related health risk is greater than 40
inches for men and 35 inches for women (S. Lemieux, Prudhomme, Bouchard, Tremblay,
& Despres, 1996). Therefore, assessments based on BMI and waist circumference can be
helpful in determining the risk for chronic health problems due to excessive weight
accumulation as measured by two different methods.
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J. Implications for Future Analysis
Up to this point, much of the empirical support regarding the causal relationship
between obesity, depression, and inflammation has been inconclusive because of the
cross-sectional design of the past research. Therefore, it is important to have more
comprehensive study designs and analytical methods to better determine the pathways
linking these variables. Additional studies on diverse sample populations using structural
equation modeling (SEM) and path analysis may be particularly helpful in determining
the best statistical fit of various proposed models pertaining to obesity, depression, and
inflammation. In addition to evaluating the model that provides the best fit to the data,
SEM could also be utilized to specify subgroups for which a particular model is more
valid (Hrabosky & Thomas, 2008). Future studies in this area should also include
longitudinal, prospective analysis of these variables to determine their relationship over
time and better understand the proposed mechanisms and association between these
factors. Additional data is also needed to analyze the nature of these variables in the
context of lifestyle interventions such as dietary and exercise modifications.
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CHAPTER 3
METHODS
A. Study Design
This study was a cross-sectional analysis of the data gathered from a sub-study of
the Adventist Health Study-2 (AHS-2) including the Psychosocial Manifestations of
Religion Sub-study (PsyMRS) and the Biological Manifestations of Religion Sub-study
(BioMRS), collectively referred to as the Biopsychosocial Religion and Health Study
(BRHS). The PsyMRS consisted of approximately 20,000 SDAs randomly selected from
the AHS-2 sample that were sent a 20 page religion and health questionnaire, in which
about 11,000 of those selected returned the questionnaire. The data collection began in
September 2006 and was largely completed by August 2007. Their return rate was
higher than originally expected, in which 60 % of the participants were Caucasians and
31 % were African Americans. One of the key categories of variables assessed from the
questionnaire was cumulative risk exposure which included physical, socioeconomic, and
psychosocial stress. Variables related to religion were also utilized, as well as other
mediating variables to help determine the religion/health connection (Lee et al., 2008).
The BioMRS consisted of approximately 508 individuals at least 35 years of age
who were selected from the PsyMRS population. Recruitment for the BioMRS involved
an initial letter sent to the participants followed by phone calls. In addition to completing
the PsyMRS questionnaire, the BioMRS participants also attended clinics in either Loma
Linda, Riverside, or Los Angeles to be assessed for biologic indicators and
anthropometric measurements (Lee et al., 2008). All participants provided a waking
saliva sample, an overnight urine sample, as well as fasting blood and adipose tissue
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samples. They also provided physical and cognitive function data, and were assessed for
various measures of allostatic load to determine their overall health risk. Anthropometric
measurements were done by graduate students who were trained by personnel familiar
with the procedures, and the biological samples were taken by certified phlebotomists
and nurses. All laboratory experiments were done by experienced laboratory technicians.
Finally, data from the BioMRS participants were utilized in the present study to
determine the association between obesity, depression, and inflammation after controlling
for demographic, socioeconomic, health behavioral, and health status variables.
B. Measurement of Variables
1. Sociodemographic Variables
Sociodemographic variables included age, gender, and ethnicity. Age was
measured in years, and gender was categorized as male or female. Ethnicity was coded
as Black or White based on self report. Race and ethnicity were divided into Black
(Black/African American, West Indian/Caribbean, African or other Black) and White
(White non-Hispanic, Hispanic, Middle Eastern, Asian, Native Hawaiian/other Pacific
Islander or American Indian) in the current analysis.
2. Socioeconomic Status
SES was assessed based on the participants’ highest level of education as
well as the degree of difficulty meeting family expenses for basic needs in the last year.
Education was categorized as follows: (a) grade school or some high school, (b) high
school or trade school diploma, (c) some college, an Associate’s degree, or a Bachelor’s
degree, and (d) a Master’s or Doctoral degree. The response choices for assessing the
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degree of difficulty meeting family expenses were not at all, a little, somewhat, fairly,
and very.
3. Health Behavior Variables
Behavioral variables included exercise, vegetarian diet consumption,
smoking, and alcohol consumption. Exercise was measured by the number of times per
week that the participant engaged in regular vigorous activities using previously validated
questions (Singh, Fraser, Knutsen, Lindsted, & Bennett, 2001; Singh, Tonstad, Abbey, &
Fraser, 1996). A 14-item food frequency questionnaire was used to assess the
participants’ dietary intake, and vegetarian status was assessed by whether or not
participants consumed (a) red meats, (b) turkey or chicken, or (c) fish over the last 12
months as three separate questionnaire items. A score of 1 indicated that participants
never or rarely consumed the food items mentioned above, and a score of 2 indicated that
participants consumed any of these foods at least 1 time per month. All values of 1 were
coded as vegetarians, and all values of 2 were coded as non-vegetarians. Smoking status
and alcohol consumption were assessed based on whether or not the participants currently
smoked or consumed alcoholic beverages at least once a week. However, since there was
only 1 current smoker and 18 participants who consumed alcohol more than 1 time per
week, we did not control for these variables in the analyses. Results did not change
substantially when analyses were run with alcohol included as a control variable (data not
shown).
4. Health Status Variables
The participants’ health status was assessed based on their risk of obesity,
depression, as well as the presence of inflammatory conditions. Obesity levels were
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assessed in two ways. First, the subjects’ body mass index (BMI) was determined based
on their height and weight as measured by trained personnel. Their weight was measured
using the scale function of the Tanita Scale, and their height was measured using a
portable stadiometer. Their BMI was then calculated in kilograms per meters squared
(reported to the nearest hundredth of a unit) to obtain the height adjusted weight. BMI
was used as a continuous variable in this analysis. However, the participants were also
classified as normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), or obese (>30
kg/m ) to determine the ethnic differences in these body weight categories (as shown in
Table 1). In addition, the subject’s waist circumference was assessed to determine the
amount of abdominal fat present. The waist circumference was taken midway between
the lower rib margin and the iliac crest and measured to the nearest millimeter.
Participant depression levels were based on an 11-item short form of the Center
for Epidemiological Studies Depression (CESD) scale which was used in the BRHS
(Kohout et ah, 1993). Scores from this scale ranged from 0 (not depressed) to 22
(severely depressed). Although each item on the questionnaire was scored on a scale
from 0 (rarely or none of the time) to 3 (most or all of the time), options 2 and 3 were
combined to make the scoring compatible with the Iowa score form. This questionnaire
was then rescaled to match the full 20 item CESD scale based on NHANES data used for
validation purposes. Rescaling also allowed comparison against a depression cutoff score
of 16 (although the participants’ CESD scores were analyzed as a continuous variable in
this study in order to provide more power). Finally, the participants were also assessed
for the presence of a disease associated with inflammation based on whether or not they
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reported any of the following conditions: type 2 diabetes, stroke, transient ischemic
attack, angina pectoris, rheumatoid arthritis, or sleep apnea.
5. Assessment of Inflammatory Markers
Serum concentrations of CRP, IL-6, IL-10 and TNF-oc were assessed
based on fasting blood samples provided by participants. These inflammatory markers
were measured by enzyme linked immunosorbent assay (ELISA) kits from Assaypro
(CRP), R & D Systems (IL-6), and ThermoScientific (IL-10 and TNF-a). The minimum
detectable dose was 100 pg/ml for CRP, 0.039 pg/ml for IL-6, 3 pg/ml for IL-10, and 2
pg/ml for TNF-a. The intra-assay and inter-assay coefficient of variation (CV) were
5.5% and 7.6% for CRP, 6.9% and 7.2% for IL-6, 8.7% and 9.4% for IL-10, and 4.2%
and 5.2% for TNF-a. All ELISA kits used were specific for the measurement of natural
human CRP, IL-6, IL-10 and TNF-a concentrations in serum, and did not cross-react
with other cytokine molecules. Standard ELISA plate readers were used to measure the
absorbance of each sample. The assessment protocol for IL-10 and TNF-a are shown in
appendix A and B, respectively.
Blood samples were stored in -70°C freezers until they were ready to be tested.
In addition, serum sample measurements of inflammatory marker concentrations were
tested in duplicate to ensure that the data is accurate and to reduce experimental error.
Therefore, the average inflammatory marker concentration values were assessed and
compared among the target population. All experimentation involving IL-10 and TNF-a
were done by the primary investigator with the assistance of a laboratory technician,
while CRP and IL-6 levels were analyzed in a different laboratory by other personnel.
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Finally, analyzing these inflammatory markers was important in determining the type of
immune response that occurs as a result of changes in the physiological system.
C. Data Management
Double data entry was used for the BioMRS data sheets to ensure that the
information was accurate. In addition, the material from the PsyMRS was scanned and
checked for inconsistencies such as out-of range responses.
D. Data Analysis
All statistical analysis was performed using SPSS (version 17). Study population
characteristics were stratified by ethnicity. Differences in the study characteristics were
determined using independent t tests for continuous variables or chi-square tests for
categorical variables (Table 1). In addition, Mann-Whitney tests were also used to
determine the differences in inflammation among blacks and whites since the CRP, IL-6,
IL-10 and TNF-values were not normally distributed and required log transformation
before regression analysis could be performed (Table 2).
Multiple linear regression analysis was utilized to test the association between
ethnicity and inflammation among the study population after controlling for
demographic, socioeconomic, behavioral and health status variables. Separate models
were utilized to test the effects of these variables on inflammation, and each model was
analyzed in a stepwise fashion. Ethnicity was included in model 1, while model 2
consisted of age, gender, education, and degree of difficulty meeting family expenses.
Model 3 included exercise and vegetarian diet consumption, and BMI was included in
model 4 (waist circumference was included in model 4 in a separate regression analysis
when BMI was not included). Model 5 additionally assessed whether the participants
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were diagnosed with an inflammatory condition. The serum concentrations of log
transformed CRP, IL-6, TNF-cc, and IL-10 served as continuous outcome variables in
separate linear regression equations.
The determinants of depression were assessed by linear regression using predictor
variables that were placed into models in a stepwise fashion as illustrated from the
regression analysis above. CESD scores served as the continuous outcome variable of
the regression equation. The association between depression and inflammatory markers
was then assessed through linear regression after controlling for the same predictor
variables mentioned above in a stepwise fashion (model 1: depression; model 2: age,
gender, ethnicity, education, degree of difficulty meeting family expenses; model 3:
exercise, vegetarian diet consumption; model 4: BMI; model 5: diagnosis of an
inflammatory condition). Log transformed CRP, IL-6, TNF-ot, and IL-10 again served as
continuous outcome variables in separate linear regression equations.
It was important to analyze the interactive effect of obesity and depression on
inflammation as well, so the product of the centered depression and obesity variables
were included in the regression analysis. Centering the depression and obesity variables
was necessary to reduce multicollinearity. An interactive effect was determined based on
whether the beta coefficient value corresponding to the obesity x depression product
differed significantly from zero. Finally, all regression analysis was based on
standardized regression coefficient values as well as R change values which were used to
determine the amount of variability in inflammation and depression explained by the
predictor variables in each of the given models.
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E. Power Analysis
For the current study, the power estimate was based on the statistical test with the
least amount of power to ensure that there was an adequate sample size to detect the
effects of the independent variables. Therefore, the association between inflammation
and each of the predictors was tested by multiple linear regression analysis based on
whether there was an increase in the multiple R when each variable was added.
According to G Power 3.0 software based on a small effect size (f=0.02), power=80%,
and cc=0.05, the sample size required at least 395 participants. Therefore, a minimum of
395 participants was needed for this study. Finally, because this was a cross-sectional
study in which the data from the questionnaires and the blood samples had already been
acquired, it was not necessary to compensate for dropout rate.
F. Study Limitations
There were several limitations to this study. First, because of the cross-sectional
nature of this study, the causal relationship between the variables could not be determined
which reduced the internal validity. In addition, the population of interest included only
SDAs consisting mainly of Black and White Adventists, which suggests that the data may
not have been representative of the larger population and may compromise external
validity. Another limitation of this study is that depression was measured from the CESD
scale and subject to self-reporting bias which could influence the reported results and
conclusions.
Due to the fact that the participants in this cohort normally maintain healthy
lifestyles, they may have been less susceptible to elevated inflammation levels compared
to other populations resulting in inflammatory marker concentrations below the minimal
45

sensitivity values on the ELISA assays. In addition, the median CESD score of this
population was 6.45, which is well below the depression cutoff score of 16. The average
BMI of the population was 26.8 kg/m2, and only 25% of the participants in this study
were obese. So there may have been an insufficient number of individuals with high BMI
and elevated depression scores for a possible interactive effect on inflammation levels.
Therefore, future analysis may require methodological changes in order to account for
these factors.
G. Research Ethics
All AHS-2 participants were eligible to participate in the BRHS. However,
consent was obtained from each participant before they began the study. All participants
were assured that their identities would remain anonymous and that all personal
information would be kept confidential. They were informed that no physical harm,
danger, or discomfort would be experienced from any of the research procedures, and
that they were free to withdraw from the study at any time. Participants were also
informed that all anthropometric measurements and biological samples would be taken
by adequately trained personnel, and that the samples would be preserved at appropriate
storage conditions. If the results showed that the participants were at high risk for health
problems, they would be referred to a specialist for the necessary treatment. Finally, the
biological and psychosocial manifestations of religion protocol for the BRHS was
approved by the Institutional Review Board of Loma Linda University. The form of
approval is shown in appendix C.
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Abstract
Background: Inflammation is a common pathophysiological pathway for a number of
chronic diseases, and is strongly influenced by sociodemographic factors and lifestyle.
Less is known about factors that may influence the inflammatory response in individuals
of distinct ethnic backgrounds. Therefore, this study examined the relationship between
ethnicity and blood levels of inflammatory markers in a sample of non-smoking church
goers.
Methods: In a cross-sectional investigation, 508 men and women (>35 years old)
participated in the Biopsychosocial substudy of the Adventist Health Study 2 (62%
White, 38% Black). The contribution of socioeconomic status (education level and
difficulty meeting expenses for basic needs) and health covariates (exercise, vegetarian or
other type of diet, body mass index, and presence of inflammatory conditions) toward
serum levels of c-reactive protein (CRT), interleukin-6 (IL-6), and tumor necrosis factoralpha (TNF-a) was assessed with linear regression models. Levels of interleukin-10 (IL10), an anti-inflammatory marker, were also assessed.
Results: Blacks showed higher levels of CRT and IL-6 than Whites. Controlling for
sociodemographic and health variables attenuated the ethnic difference in CRP while IL6 levels remained higher in Blacks than in Whites (p = 0.118; 95% confidence interval =
0.014 - 0.206; p = 0.025). Ethnic differences in IL-10 and TNF-a were not found.
Vegetarian diet was associated with lower CRP levels while exercise frequency was
associated with higher IL-10 levels.
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Conclusion: Higher susceptibility of Blacks to inflammatory diseases may reflect higher
IL-6, which could be important in assessing health disparities among Blacks and Whites.
Vegetarian diet and exercise may counteract effects of disparities.
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INTRODUCTION
Ethnic differences in chronic disease incidence have been widely studied, with
Blacks having a higher risk of hypertension, stroke and renal failure compared to
Whites.1 The reason for this disparity has not been completely elucidated but may be due
to increased prevalence of disease risk factors among Blacks. Inflammation has been
determined to be an important factor associated with chronic diseases, and is often
indexed by elevated circulating levels of C-reactive protein (CRT) and pro-inflammatory
cytokines. Behavioral factors have a direct impact on inflammatory processes.
Large epidemiologic studies have shown that CRT and pro-inflammatory
cytokines increase with age in both men and women.4"6 In addition, several studies have
found that females have higher levels of CRP compared to men, possibly due to higher
amounts of fat tissue among women.7'8 The association between ethnicity and
inflammation has been analyzed as well, showing that Blacks often have higher CRP than
Whites. 9-11 Other inflammatory molecules include interleukin 6 (IL-6) and tumor
necrosis factor-a (TNF-a) which are associated with a pro-inflammatory response while
IT-10 has anti-inflammatory effects.

19

Some studies have shown that Blacks have higher

IL-6 levels than Whites, 11, 13 but it is unclear whether IT-10 and TNF-a levels vary
according to ethnic background. 13-15
Ethnic specific differences in inflammation may have diverse determinants. For
instance, low socioeconomic status (SES) has been associated with increased levels of
CRP, IL-6 and TNF-a. 16-17 It is therefore possible that SES may partially explain why
certain ethnicities are at higher risk for inflammatory problems. Health behavior factors
also play a role in inflammation. For example, physical activity has been associated with
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lower circulating levels of CRP and IL-6 in both healthy and patient populations18 and
has been shown to increase concentrations of anti-inflammatory cytokines (such as IL-1
receptor antagonist and IL-10) to lower the inflammatory response.19 In addition, diets
rich in fruits, vegetables, whole grains and nuts have been associated with reductions in
CRP and IL-6 levels, while diets high in refined grains, red meat, and high fat dairy have
been directly correlated with increased inflammation. 20-21
Alcohol consumption has also been associated with lower levels of CRP among
moderate drinkers compared to non-drinkers and heavy drinkers, a U-shaped pattern. 22-23
Cigarette smoking has been found to be a potent risk factor for increased levels of lowgrade inflammation based on elevated CRP and IL-6 levels. 24-26
One of the populations in which determinants of chronic disease have been
studied is Seventh-day Adventists, a conservative religious group that abstain from
alcohol and tobacco. 27-28 Thus, the population avoids some of the major identified factors
involved in increasing inflammation and may provide the opportunity to illuminate the
role of other factors, including ethnicity and lifestyle factors. In the present study ethnic
differences in inflammation were assessed among a population of church going
Adventists. We also determined whether the ethnicity-inflammation relationship is
affected by demographic (age and gender), SES (education level and difficulty meeting
expenses for basic needs), behavioral (exercise and vegetarian diet) or health status
variables (body mass index [BMI] and diagnosis of an inflammatory condition). The
inflammatory markers that were analyzed include both pro-inflammatory (IL-6 and TNFot) and anti-inflammatory (IL-10) cytokines as well as an acute phase protein (CRP).
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METHODS
A. Study Population
This study was a cross-sectional analysis of the data gathered from a sub-study of
the Adventist Health Study-2 (AHS-2) referred to as the Biopsychosocial Religion and
Health Study (BRHS).

Approximately 20,000 subjects randomly selected from the

96,000 case AHS-2 sample were sent a 20 page religion and health questionnaire, and
about 11,000 returned the questionnaire. The data collection began in September 2006
and was largely completed by August 2007. The study population consisted mainly of
Black and White, Seventh-day Adventist males and females who were at least 35 years of
age. In addition to completing the questionnaire, 508 BRHS participants also attended
study-specific clinics in Loma Linda, Riverside, or Los Angeles to be assessed for
biologic indicators and anthropometric measurements. Cytokine analysis was based on
fasting blood samples provided by the participants on the day they attended the clinic.
The institutional review board at Loma Linda University approved the study protocol,
and informed consent was obtained from all participants.
B. Measurement of Variables
1. Sociodemographic Variables
Sociodemographic variables included age, gender, and ethnicity.
Ethnicity was coded as Black or White based on self report. Race and ethnicity were
divided into Black (Black/African American, West Indian/Caribbean, African or other
Black) and White (White non-Hispanic, Hispanic, Middle Eastern, Asian, Native
Hawaiian/other Pacific Islander or American Indian) in the current analysis.
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2. Socioeconomic Status
SES was assessed based on the participants’ highest level of education as
well as the degree of difficulty meeting family expenses for basic needs in the last year.
Education was categorized as follows: (a) grade school or some high school, (b) high
school or trade school diploma, (c) some college, an Associate’s degree, or a Bachelor’s
degree, and (d) a Master’s or Doctoral degree. The response choices for assessing the
degree of difficulty meeting family expenses were not at all, a little, somewhat, fairly,
and very.
3. Health Behavior Variables
Behavioral variables included exercise, vegetarian diet, smoking, and
alcohol consumption. Exercise was measured by the number of times per week that the
participant engaged in regular vigorous activities using previously validated questions.30
31

A 14-item food frequency questionnaire was used to assess the participants’ dietary

intake, and vegetarian status was assessed by whether or not participants consumed (a)
red meats, (b) turkey or chicken, or (c) fish over the last 12 months as three separate
questionnaire items. A score of 1 indicated that participants never or rarely consumed the
food items mentioned above, and a score of 2 indicated that participants consumed any of
these foods at least 1 time per month. All values of 1 were coded as vegetarians, and all
values of 2 were coded as non-vegetarians. Smoking status and alcohol consumption
were assessed based on whether or not the participants currently smoked or consumed
alcoholic beverages at least once a week. However, since there was only 1 current
smoker and 18 participants who consumed alcohol more than 1 time per week, we did not
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control for these variables in the analyses. Results did not change substantially when
analyses were run with alcohol included as a control variable (data not shown).
4. Health Status Variables
The participants’ health status was assessed based on their height, weight,
and calculated BMI as well as the presence of inflammatory conditions. The participants
were assessed for the presence of a disease associated with inflammation based on
whether or not they reported any of the following conditions: type 2 diabetes, stroke,
transient ischemic attack, angina pectoris, rheumatoid arthritis, or sleep apnea.
5. Inflammatory Markers
Serum concentrations of CRP, IL-6, IT-10 and TNF-a were assessed
based on fasting blood samples provided by participants that were processed and stored
in -70°C freezers until they were ready to be tested. These inflammatory markers were
measured in duplicate by enzyme linked immunosorbent assay (ELISA) kits from
Assaypro (CRP), R & D Systems (IL-6), and ThermoScientific (IL-10 and TNF-a). The
minimum detectable dose was 100 pg/ml for CRP, 0.039 pg/ml for IL-6, 3 pg/ml for IL10, and 2 pg/ml for TNF-a. The intra-assay and inter-assay coefficient of variation (CV)
were 5.5% and 7.6% for CRP, 6.9% and 7.2% for IL-6, 8.7% and 9.4% for IL-10, and
4.2% and 5.2% for TNF-a. All ELISA kits used were specific for the measurement of
natural human CRP, IL-6, IL-10 and TNF-a concentrations in serum, and did not crossreact with other cytokine molecules. Standard ELISA plate readers were used to measure
the absorbance of each sample.
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C. Statistical Analysis
All statistical analysis was performed using SPSS (version 17). Ethnic
differences in the study characteristics were determined using independent t tests for
continuous variables or chi-square tests for categorical variables (Table 1). In addition,
Mann-Whitney tests were also used to determine the differences in inflammation between
Blacks and Whites since the CRP, IL-6, IL-10 and TNF-values were not normally
distributed and required log transformation before regression analysis could be performed
(Table 2).
Multiple linear regression analysis was utilized to test the association between
ethnicity and inflammation among the study population after controlling for
demographic, socioeconomic, behavioral and health status variables. Separate models
were utilized to test the effects of these variables on inflammation, and each model was
analyzed in a stepwise fashion. Ethnicity was included in model 1, while model 2 added
age, gender, education, and degree of difficulty meeting family expenses. Model 3
additionally added exercise and vegetarian diet consumption, and BMI was included in
model 4. Model 5 added whether the participants were diagnosed with a medical
condition. The serum concentrations of log transformed CRP, IL-6, TNF-a, and IL-10
served as continuous outcome variables in separate linear regression equations. Cytokine
concentrations below the limit of detection of were given a value of 0.001 representing a
near zero value as demonstrated in a previous study.

T9

The regression analysis was based

on standardized regression coefficient values as well as R change values which were
used to determine the amount of variability in inflammation explained by the predictor
variables in each of the given models.
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RESULTS
The study population characteristics and differences between Blacks and Whites
are shown in Table 1. The mean age of the population was 68.8 years (range: 36 - 102);
63% of the participants were women and 37% were Black. Black participants were
younger, achieved a lower level of education, and had more difficulty meeting family
expenses for basic needs in the last year. Blacks were also less likely to consume a
vegetarian diet, and had a higher mean BMI and waist diameter value. Table 2 shows
that higher levels of CRP and IL-6 were present among Black participants compared to
the White participants while IL-10 and TNF-a levels did not differ between the two
groups.
Regression coefficients for the association of each predictor variable with serum
concentrations of CRP, IL-6, IL-10 and TNF-a are illustrated in Table 3, 4, 5 and 6,
respectively. CRP levels were found to be significantly higher among Blacks than
Whites, but this relationship was no longer significant after controlling for the
demographic and SES variables in model 2. After controlling for all covariates, CRP
levels were positively associated with age, female gender, BMI, and non-vegetarianism
(Table 3). IL-6 was positively associated with age, BMI, and Black ethnicity after
controlling for all other factors. Increased exercise frequency was associated with a
decrease in IL-6 levels, while consumption of a vegetarian diet was associated with a
decrease in IL-10 levels. However, these relationships were no longer significant after
controlling for BMI (Table 4 and 5). Nevertheless, IL-10 was positively associated with
exercise frequency after controlling for all other covariates.

56

2

The R change values were also provided in Tables 3-6. A significant proportion
of variability in CRT was explained by ethnicity (F (1, 432) = 3.979, p = 0.047), age.
gender, education, and difficulty meeting family expenses for basic needs (F (4, 428) =
5.409, p = 0.000), health behavior variables (F (2, 426) = 9.298, p = 0.000), and BMI (F
(1,425) = 53.844, p = 0.000). Likewise, ethnicity (F (1, 432) = 6.511, p = 0.011), age,
gender, education, and difficulty meeting family expenses for basic needs (F (4, 428) =
4.042, p = 0.003), health behavior variables (F (2, 426) = 3.090, p = 0.047) and BMI (F
(1,425) = 8.644, p = 0.003) also explained significant amounts of variability in IL-6
levels. Finally, health behavior variables (mainly exercise frequency) explained a
significant proportion of IL-10 variability based on the regression analysis provided (F
(2, 397) = 5.137, p = 0.006).
DISCUSSION
This study has shown that IL-6 may serve as an important ethnic-specific cytokine
that is higher among Blacks than Whites, while the other inflammatory markers or anti
inflammatory marker (IL-10) did not differ between Blacks and Whites. Healthy lifestyle
behaviors were associated with a lower inflammatory status, after controlling for ethnic
differences, as increased exercise frequency was associated with increased IL-10 levels,
and consumption of a vegetarian diet was associated with lower CRP levels.
The present study provides further evidence of an association between ethnicity
and inflammation, in line with other studies that have found higher IL-6 levels among
Blacks compared to Whites. 13,33-34 However, these studies did not control for variables
related to lifestyle practice (such as diet or exercise) when assessing the ethnic
differences in IL-6, and may be confounded by differences between Blacks and Whites in
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regard to these factors. Earlier study designs were based on a much smaller sample size
than was used for the current investigation.
Adipose tissue synthesizes inflammatory markers such as IL-6, and increased
body mass has been associated with higher inflammation levels among Blacks. 35-36
However, the ethnic specific difference in IL-6 was significant even after controlling for
BMI in the current study, so other factors may be responsible for this relationship. One
possible reason for the ethnic variations in the level of this cytokine is due to differences
in cytokine gene polymorphisms. It has been suggested that specific allelic variations in
the regulatory regions of inflammatory cytokine genes may alter the expression of some
cytokines.

One of the genotypes that results in high IL-6 production (G/G IL-6

genotype) has been predominantly found in Blacks, and may explain higher levels of this
cytokine among this ethnic group.38
Although there were higher CRP levels among Blacks in the present study, this
association was no longer significant after controlling for the other covariates. Studies
among the US population have shown that there are higher CRP levels among Blacks in
relation to Whites.7,39-41 However, like the results from the present study, the ethnicityCRP association found in some of the investigations ultimately disappeared after
controlling for various health-related factors. 42-43 In the current study, the ethnicity-CRP
relationship was largely attenuated after controlling for vegetarian diet consumption as
well as exercise frequency, and even more attenuated after controlling for BMI.
Therefore, future studies should investigate lifestyle components as well as other
variables associated with obesity that may serve as important mediating factors between
ethnicity and CRP.
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No significant differences in IL-10 and TNF-oc levels were found between Black
and White subjects in the present study. Although lower levels of IL-10 among Blacks
compared to Whites have been reported previously,14 the analysis was based on
stimulated peripheral blood samples rather than basal cytokine levels in the blood.
Therefore, no direct evidence of ethnic differences in circulating IL-10 levels was shown.
As far as ethnic differences in TNF-a are concerned, the results are mixed. A study by
Kalra et al found that TNF-a levels were higher among Blacks in relation to Whites
from the UK, while Elkind et al15 found no significant difference in TNF-a levels among
Blacks and Whites from the US. Therefore, geographic location and environmental
factors may play an important role in the onset of inflammation among different ethnic
groups.
Based on the results provided, engaging in exercise and consuming a vegetarian
diet did appear to provide health benefits. We found that a vegetarian diet was associated
with a reduction in CRP which is in accordance with previous research showing that
long-term vegetarians have a lower risk of coronary heart disease and an improved
antioxidant and inflammatory status compared to non-vegetarians.44 In addition, greater
amounts of regular physical activity have been associated with elevated IL-10 levels in
healthy older males,45 and aerobic exercise training has been reported to exert anti
inflammatory effects in type 2 diabetics due to increases in IL-10 concentrations.46
Specifically, high intensity exercise has been more strongly associated with increased IL10 levels when compared to moderate and light intensity exercises among healthy, welltrained participants,47 suggesting that more vigorous exercise may provide stronger anti
inflammatory effects.
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Strengths and Limitations
This study assessed pro-inflammatory and anti-inflammatory cytokines that were
not examined together in previous studies. The absence of cigarette smokers and low
amount of alcohol consumption allowed the confounding effects of smoking and excess
alcohol on inflammatory markers to be avoided. Finally, the current study sample size
provided sufficient power for detecting associations between the study variables.
This was a cross-sectional study so causality between ethnicity and other
variables and levels of inflammatory markers cannot be assumed. There were differences
in baseline factors between Blacks and Whites. We adjusted for these factors, but residual
confounding may remain. The study population consisted of only Adventist church goers
and generalizability to the larger population may be limited. Genetic markers of the
inflammatory cytokines were not examined, limiting our analysis to cytokine
concentrations rather than specific gene activity. More importantly, this population of
church goers may have been less susceptible to increased inflammation based on their
overall health and lifestyle practices, making it difficult to detect some of the
inflammatory markers. Therefore, since the TNF-oc concentration of many of the study
participants was below the limit of detection, future analysis of inflammation using TNFreceptor 1 as a surrogate marker for TNF-ot may be preferable since TNF-oc has a short
half-life (~15 minutes) and can be difficult to detect among certain populations using
standard ELISA kits. 48
Conclusion
Inflammatory based risk for health problems may vary according to ethnicity and
other demographic factors. Yet inflammation levels also seem to be influenced by other
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variables such as diet, exercise, and overall body mass. Interventions that focus on
improving these health behaviors may therefore be the key to reducing the risk for
chronic diseases.
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Table 1. Main characteristics of the study population according to ethnicity
Factor
Age in years (Mean (SD))

Whites
(n =314)
71.4(11.6)

Blacks
(n =191)
64.4(10.1)

P-value
(Whites vs Blacks)
0.000

Total Population
(n=505)
68.8 (11.6)

Gender (n (%))
Male
Female

128(41.0)
184 (59.0)

58 (30.5)
132 (69.5)

0.018

186 (37.1)
316(62.9)

5 (1.6)
11 (3.5)

5 (2.7)
19(10.1)

146 (47.1)
148 (47.7)

124 (66.0)
40(21.3)

264 (85.2)
26 (8.4)
8 (2.6)
6(1.9)
6(1.9)

Education (n (%))
Grade school or some high school
High school or Trade school diploma
Some college, Associate’s degree, or
Bachelor’s degree
Master’s or Doctoral degree

10(2.0)
30 (6.0)
0.000

270 (54.2)
188 (37.8)

138 (74.6)
25 (13.5)
6 (3.2)
10(5.4)
6 (3.2)

0.043

402 (81.2)
51 (10.3)
14(2.8)
16(3.2)
12(2.4)

299 (95.5)
14(4.5)

187 (97.9)
4(2.1)

0.163

486 (96.4)
18(3.6)

Frequency of Vigorous Activities per Week
(n (%))
Never or less than once per week
1-2 times per week
3-4 times per week
5 or more times per week

108 (36.4)
51 (17.2)
81 (27.3)
57(19.2)

63 (35.4)
29(16.3)
66 (37.1)
20(11.2)

0.048

171 (36.0)
80(16.8)
147 (30.9)
77(16.2)

Vegetarian Diet
Non-vegetarian
Vegetarian

152 (48.4)
162 (51.6)

137(71.7)
54 (28.3)

0.000

289 (57.2)
216(42.8)

BMI (Mean (SD))
Normal Weight (n (%))
Overweight (n (%))
Obese (n (%))

25.7 (4.7)
151 (48.1)
107 (34.1)
56(17.8)

28.7(5.9)
61 (31.9)
62 (32.5)
68 (35.6)

0.000

0.000

26.8 (5.4)
212(42.0)
169 (33.5)
124 (24.6)

35.9(5.5)

37.6(6.3)

0.004

36.6(5.9)

236 (75.2)
78 (24,8)

121 (65.4)
64 (34,6)

0.020

357 (71.5)
142 (28,5)

Difficulty meeting family expenses for
basic needs in last year (n (%))
Not at all
A little
Somewhat
Fairly
Very
Alcohol consumption within the last 12
months (n (%))
Consumed 3 drinks or less per month
Consumed 4 drinks per month or
more

Waist Diameter (Mean (SD))
Diagnosed with any of the following
conditions (n (%)):
Type 2 Diabetes, Stroke, TIA, Angina
Pectoris, Rheumatoid Arthritis, Sleep
Apnea
No Disease Diagnosis
Diagnosed with Disease
SD = standard deviation
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Table 2. Ethnic differences in inflammatory marker concentrations

Inflammatory Marker
Concentrations (Median (IQR))
CRP (mg/ml)
IL-6 (pg/ml)
IL-10 (pg/ml)
TNF-a (pg/ml)

P-value

Total Population
(n=493)

Whites
(n=306)

Blacks
(n=187)

(Whites vs
Blacks)

0.10(0.04-0.24)
2.72(1.59-5.62)
5.38 (3.24-8.80)
0.01 (0.01-7.49)

0.09(0.04-0.21)
2.34(1.53-4.52)
5.11 (2.96-8.80)
0.001 (0.001-8.07)

0.12(0.05-0.29)
3.37(1.95-7.40)
5.83 (3.74-9.03)
0.001 (0.001-7.38)

0.010
0.000
0.082
0.668

IQR = interquartile range, CRP = c-reactive protein, IL-6 = interleukin-6, IL-10 = interleukin 10, TNF-a =
tumor necrosis factor alpha
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Table 3. Regression analysis models illustrating the association between various predictor variables and CRT
Factor
Ethnicity
Blacks vs Whites

P
0.096

Model 1
B (SE) P-value
0.108
(0.054)

Model 2
B (SE) P-value

p

Model 3
B (SE) P-value

p

Model 4
B (SE) P-value

P

Model 5
B (SE) P-value

0.093

0.105
(0.057)

0.067

0.060

0.068
(0.057)

0.230

-0.008

-0.009
(0.054)

0.866

-0.009

-0.011
(0.055)

0.847

Age

0.108

0.005
(0.002)

0.029

0.101

0.005
(0.002)

0.040

0.129

0.006
(0.002)

0.006

0.126

0.006
(0.002)

0.009

Gender
Females vs Males

0.175

0.193
(0.054)

0.000

0.172

0.190
(0.053)

0.000

0.183

0.202
(0.050)

0.000

0.184

0.203
(0.051)

0.000

Education

-0.059

-0.049
(0.042)

0.247

-0.008

-0.007
(0.043)

0.875

-0.001

-0.001
(0.040)

0.979

-0.001

0.000
(0.040)

0.991

0.009

0.006
(0.029)

0.845

0.006

0.003
(0.028)

0.904

-0.005

-0.003
(0.027)

0.902

-0.006

-0.004
(0.027)

0.893

Frequency of vigorous
activities per week

-0.110

-0.026
(0.011)

0.022

-0.059

-0.014
(0.011)

0.197

-0.058

-0.013
(0.011)

0.207

Vegetarian diet
Vegetarian vs NonVegetarian

-0.170

-0.185
(0.053)

0.000

-0.108

-0.118
(0.051)

0.020

-0.107

-0.117
(0.051)

0.023

0.344

0.036
(0.005)

0.000

0.341

0.036
(0.005)

0.000

0.014
(0.057)

0.803

Difficulty meeting
family expenses in the
last year

0.047

p

Os

Body Mass Index
Inflammatory Condition
Diagnosis
Disease vs No
Disease
R2 Change

0.012

0.009

0.048

0.039

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.102

0.000

Table 4. Regression analysis models illustrating the association between various predictor variables and IL-6
Factor
Ethnicity
Blacks vs Whites

P
0.122

Model 1
B (SE) P-value
0.113
(0.044)

0.011

P

Model 2
B (SE)
P-value

0.165

0.153
(0.047)

0.001

Age

0.180

0.007
(0.002)

0.000

Gender
Females vs Males

-0.005

-0.004
(0.045)

Education

-0.072

P
0.154

Model 3
B (SE) P-value
0.143
(0.047)

0.003

0.163

0.006
(0.002)

0.924

-0.017

-0.049
(0.035)

0.157

-0.021
(0.024)

0.388

p

P

Model 5
B (SE) P-value

0.115
(0.048)

0.016

0.121

0.113
(0.048)

0.020

0.001 0.175

0.007
(0.002)

0.000

0.167

0.006
(0.002)

0.001

-0.015
(0.045)

0.732

-0.012

-0.011
(0.044)

0.805

-0.010

-0.009
(0.045)

0.843

-0.050

-0.034
(0.036)

0.338

-0.047

-0.032
(0.035)

0.363

-0.045

-0.031
(0.035)

0.383

-0.044

-0.022
(0.024)

0.356

-0.049

-0.024
(0.024)

0.303

-0.051

-0.025
(0.024)

0.290

Frequency of vigorous
activities per week

-0.116

-0.022
(0.009)

0.018

-0.094

-0.018
(0.009)

0.055

-0.091

-0.017
(0.009)

0.063

Vegetarian diet
Vegetarian vs NonVegetarian

-0.029

-0.026
(0.044)

0.556

-0.003

-0.002
(0.044)

0.957

0.001

0.001
(0.045)

0.988

0.147

0.013
(0.004)

0.003

0.141

0.012
(0.004)

0.006

Difficulty meeting
family expenses in the
last year

0.042

0.124

Model 4
B (SE)
P-value

Os
GO

Body Mass Index
Inflammatory Condition
Diagnosis
Disease vs No
Disease
R2 Change

0.030

0.015

0.036

0.014

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.019

0.030
(0.050)

0.001

0.554

Table 5. Regression analysis models illustrating the association between various predictor variables and IL-10
Factor
Ethnicity
Blacks vs Whites

CTn
VO

(3
0.054

Model 1
B (SE) P-value
0.080
(0.073)

0.275

P

Model 2
B (SE)
P-value

p

Model 3
B (SE) P-value

p

Model 4
B (SE)
P-value

P

Model 5
B (SE) P-value

0.051

0.074
(0.079)

0.344

0.044

0.064
(0.079)

0.416

0.028

0.041
(0.080)

0.611

0.029

0.042
(0.081)

0.599

Age

-0.009

-0.001
(0.003)

0.858

0.024

0.001
(0.003)

0.646

0.031

0.002
(0.003)

0.558

0.034

0.002
(0.003)

0.535

Gender
Females vs Males

0.006

0.008
(0.075)

0.911

0.033

0.047
(0.075)

0.532

0.037

0.054
(0.075)

0.473

0.036

0.052
(0.076)

0.489

Education

-0.026

-0.028
(0.058)

0.629

-0.022

-0.024
(0.059)

0.685

-0.019

-0.021
(0.059)

0.723

-0.020

-0.022
(0.059)

0.715

Difficulty meeting
family expenses in the
last year

-0.051

-0.040
(0.040)

0.318

0.048

-0.038
(0.040)

0.343

-0.049

-0.039
(0.040)

0.334

-0.048

-0.038
(0.040)

0.345

Frequency of vigorous
activities per week

0.137

0.041
(0.016)

0.008

0.148

0.045
(0.016)

0.005

0.147

0.044
(0.016)

0.005

Vegetarian diet
Vegetarian vs NonVegetarian

-0.102

-0.146
(0.074)

0.049

-0.091

-0.130
(0.075)

0.084

-0.092

-0.132
(0.076)

0.082

0.073

0.010
(0.007)

0.171

0.076

0.010
(0.008)

0.168

-0.018
(0.085)

0.832

Body Mass Index
Inflammatory Condition
Diagnosis
Disease vs No
Disease
R1 Change

-0.012

0.003

0.003

0.025

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.005

0.000

Table 6. Regression analysis models illustrating the association between various predictor variables and TNF-a
Factor

Model 1
B (SE) P-value

P

Model 2
B (SE)
P-value

p

Model 3
B (SE)
P-value

P

Model 4
B (SE)
P-value

P

Model 5
B (SE)
P-value

-0.003

-0.011
(0.223)

0.962

-0.004

-0.017
(0.226)

0.939

-0.011

-0.048
(0.232)

0.837

-0.011

-0.047
(0.233)

0.840

Age

-0.012

-0.002
(0.009)

0.820

-0.011

-0.002
(0.009)

0.829

-0.008

-0.001
(0.009)

0.876

-0.008

-0.001
(0.009)

0.885

Gender
Females vs Males

-0.101

-0.418
(0.213)

0.050

-0.101

-0.417
(0.216)

0.055

-0.099

-0.407
(0.217)

0.061

-0.099

-0.408
(0.218)

0.062

Education

0.037

0.114
(0.165)

0.490

0.040

0.122
(0.170)

0.474

0.041

0.126
(0.170)

0.460

0.041

0.126
(0.171)

0.462

Difficulty meeting
family expenses in the
last year

-0.008

-0.019
(0.115)

0.868

-0.008

-0.019
(0.115)

0.868

-0.009

-0.020
(0.116)

0.862

-0.009

-0.020
(0.116)

0.864

Frequency of vigorous
activities per week

-0.003

-0.002
(0.045)

0.957

0.002

0.002
(0.045)

0.963

0.002

0.002
(0.046)

0.965

Vegetarian diet
Vegetarian vs NonVegetarian

-0.010

-0.041
(0.214)

0.847

-0.005

-0.021
(0.216)

0.923

-0.005

-0.021
(0.218)

0.922

0.033

0.013
(0.021)

0.535

0.034

0.013
(0.022)

0.543

-0.001

-0.006
(0.246)

0.981

Ethnicity
Blacks vs Whites

>4

p
-0.019

-0.081
(0.209)

0.699

O

Body Mass Index
Inflammatory Condition
Diagnosis
Disease vs No Disease
R1 Change

0.000

0.013

0.000

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.001

0.000

CHAPTER 5
ADDITIONAL FINDINGS
Inflammation is an important part of any healthy biological system, but can be
affected by many different factors. Additional findings from the present study may be
useful in assessing the subjects’ overall health status and risk for inflammatory problems.
Topics to be discussed include the effects of age, gender, waist circumference, and
depression on the other study variables including inflammation.
A. Effects of Age and Gender
In addition to the ethnic differences in inflammation mentioned in chapter 4,
evidence of gender and age-related changes in inflammation were also found and
commented on here due to insufficient space in Chapter 4. Gender specific differences in
CRP have been illustrated in many studies with similar outcomes to the current study
results in which females had consistently higher CRP levels than males (Khera et ah,
2005; Nazmi & Victora, 2007; Valentine, Vieira, Woods, & Evans, 2009; Zhang et ah,
2008). Large scale studies conducted in the US reported similar findings, including the
Multiethnic Study of Atherosclerosis which found higher CRP levels in females than
males among a population of Caucasian, African American, Hispanic, and Chinese
participants. The gender differences in CRP remained significant after accounting for
potential confounding variables as well (Lakoski et ah, 2006). Since SES, health
behavioral, and health status variables did not affect the gender-CRP relationship in the
present study, it is possible that gender may be an independent determinant of changes in
CRP levels based on physiological or genetic differences between males and females.
Prior studies that examined large populations of adults have also found age related
71

increases in IL-6 and CRP (Ballou et al., 1996; Ershler et al., 1993; Stowe et al., 2009;
Wei, Xu, Davies, & Hemmings, 1992). Elderly individuals may therefore be affected by
a low grade pro-inflammatory state characterized by increased levels of cytokines and
acute phase proteins. However, it is unclear whether the inflammatory state associated
with aging results from an impaired mechanism that prevents the inflammatory response
from shutting off, or is due to an accumulation of unhealthy lifestyle practices (Ferrucci
et al., 2005). The age-inflammation association in the present study remained significant
after controlling for SES and health behavior factors, so it is more likely that an age
associated dysregulation of IL-6 and CRP production may have affected this population
of SDAs. Accumulated stress may lead to a reduced compensatory effect resulting in
loss of equilibrium between cytokines and stress hormones, which could be responsible
for the age associated increase in inflammation (Butcher & Lord, 2004). Reduced
concentrations of sex hormones, growth hormones, and Vitamin D levels that accompany
the aging process have also been associated with increases in inflammatory protein
concentrations (Hunt, Walsh, Voegeli, & Roberts, 2010a), and should be investigated
through further study.
B. Effects of Waist Circumference
Waist circumference was assessed as an indicator of obesity in the present study,
and showed the same associations with the markers of inflammation as BMI. In addition,
there was a high correlation between BMI and waist circumference so their associations
with CRP, IL-6, IE-10, and TNF-oc were assessed through separate regression analysis.
Because these two obesity assessment parameters were significantly correlated with CRP
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and IL-6 levels, BMI and waist circumference may both be reliable tools for determining
inflammatory health risk.
C. Effects of Depression
Evidence has shown that depression is often associated with increased levels of
inflammation (Howren, Lamkin, & Suls, 2009; J. C. Stewart, Rand, Muldoon, &
Kamarck, 2009). The depression-inflammation relationship was therefore an important
area to investigate among the current population of SDAs. Knowing which factors are
associated with depression may be important in identifying subjects at high risk for
depression related health problems. Therefore, regression analysis was utilized to
determine the contribution of demographic (age, gender and ethnicity), socioeconomic
(education level and difficulty meeting family expenses for basic needs), health
behavioral (exercise and vegetarian diet) and health status variables (body mass index
and diagnosis of an inflammatory condition) toward depression scores based on the 11
item short form of the Center for Epidemiological Studies Depression (CESD) scale. The
predictor variables were placed into separate models and analyzed in a stepwise fashion
as described in chapter 3. Regression models were also used to determine the association
between depression and each of the markers of inflammation (CRP, IL-6, IE-10, and
TNF-oc) using the same control variables mentioned above.
Regression coefficients for the association between each predictor variable and
depression are illustrated in table 7. Higher depression scores were found among females
compared to males, and depression was positively correlated with BMI, increased
difficulty meeting family expenses in the last year, and the diagnosis of an inflammatory
condition. These associations were found after controlling for all other covariates.
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Interestingly, consumption of a vegetarian diet was associated with decreased depression,
but this relationship was no longer significant after controlling for the diagnosis of an
inflammatory condition. As shown in tables 8-11, depression scores were not
significantly correlated with any of the inflammatory markers in the regression models
provided. This may have occurred since many SDAs from the current study reported low
CESD scores, in which 82% of the depression scores were below the depression cutoff
value of 16. In addition, a recent meta-analysis by Howren et al (2009) showed that
stronger associations exist between depression and inflammatory cytokines among
clinically depressed populations that were assessed using clinical interviews compared to
community based samples that were assessed using self-report measures of depression.
Therefore, the method used to measure depression levels in the present study may have
contributed to the results found. Finally, incorporating depression scores into the
regression analysis did not significantly change the correlation coefficient values between
the other predictor variables and each of the inflammatory markers when compared to the
previous regression models in chapter 4 when depression was not analyzed.
R change values were also provided in tables 7-11. Factors such as age, gender,
education, and degree of difficulty meeting family expenses for basic needs (F (4, 429) =
9.676, p = 0.000), as well as health behavior variables (F (2, 427) = 4.936, p = 0.008),
BMI (F (1, 426) = 7.999, p = 0.005), and inflammatory conditions (F (1, 425) = 9.309, p
= 0.002) were responsible for significant variability in depression (table 7). As illustrated
by the R2 change values in tables 8-11, CRP, IL-6, IL-10, and TNF-a were not
significantly associated with depression among the target population.
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The results from the regression analysis showed that depression did not differ
according to ethnicity but did vary according to gender. Many studies have shown that
females exhibit higher depression levels than men (Kessler, McGonagle, Swartz, Blazer,
& Nelson, 1993; Lucht et ah, 2003; Piccinelli & Wilkinson, 2000; Weissman & Klerman,
1977), but the results are mixed regarding differences in depression between Blacks and
Whites. Although there is evidence that Black people experience higher rates of
depressive symptoms than White people (Dunlop, Song, Lyons, Manheim, & Chang,
2003; Plant & Sachs-Ericsson, 2004; Tweed et ah, 1990), some studies that used
diagnostic criteria for major depression typically found no ethnic differences in
depression (F. Y. Huang, Chung, Kroenke, & Spitzer, 2006; Somervell, Leaf, Weissman,
Blazer, & Bruce, 1989). One of the reasons for the discrepancy may be that Blacks often
have lower SES than Whites but still maintain high levels of social support (Plant &
Sachs-Ericsson, 2004). In the present study, Black SDAs were less educated and had
more difficulty meeting family expenses for basic needs in the last year compared to
White SDAs. Previous studies have shown that chronic resource deficit can have a
negative impact on people’s psychological well-being due to stress which can be a strong
predictor of depression (Ennis, Hobfoll, & Schroder, 2000; Hobfoll, Johnson, Ennis, &
Jackson, 2003). However, increased social support has been associated with reduced
levels of depression (Plant & Sachs-Ericsson, 2004). No ethnic differences in social
support were found in the present study, so it is possible that social support may be a
stronger determinant of ethnic related depression levels among SDAs than SES. Future
studies among different ethnic populations should therefore analyze the effects of SES
and social support on depression.
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Depression has been shown to vary according to gender. Estimates have shown
that nearly twice as many women are depressed as men in adulthood (Lucht et ah, 2003),
and the World Health Organization has indicated that major depression is the leading
cause of disease related disability worldwide among females (Kessler, 2003). Research
also indicates that the gender difference in depression emerges during adolescence and
may result from a variety of factors, including women’s higher level of affiliative needs,
self-esteem fluctuation, body dissatisfaction, and exposure to negative events throughout
life (Hyde, Mezulis, & Abramson, 2008). Fluctuations in hormone levels that occur
during puberty (such as DHEA, estrogen, and testosterone) may also be responsible for
higher depression among females and should be analyzed in further studies (Remer,
Boye, Hartmann, & Wudy, 2005; van Broekhoven & Verkes, 2003). Another important
area of future research will be to identify the genes that contribute to the gender
difference in depression and determine whether gene interactions occur.
Body mass index (BMI) was also positively associated with depression after
controlling for the other covariates in the present study. Indeed, cross-sectional studies
have shown that there is a positive association between depression and increased body
weight (McElroy et al., 2004; Rosmond, 2004), and longitudinal studies have found that
obesity may predict later onset of depression in adults (Roberts et al., 2002). Some
discrepancies exist in the literature which may be a result of variations in demographic
factors such as age, gender, and ethnicity (Greenman & Stem, 2007). Therefore, the
association between body mass index and depression may vary based on the population
studied. The type of depression experienced by an individual can also affect his or her
weight differently. Typical or melancholic depression is often associated with anorexia
76

and decreased food intake, while atypical depression is primarily characterized by
increased appetite and weight gain (Dipietro et ah, 1992). Nevertheless, obesity and
depression may co-exist due to the presence of common emotional factors. The negative
thoughts and attitudes characteristic of depression may contribute to weight management
problems due to low levels of self-efficacy (Markowitz et ah, 2008), and obesity may
contribute to a poor self -image and, hence, increased risk of depression.
Depression was positively associated with the diagnosis of inflammatory
conditions such as type 2 diabetes, stroke, transient ischemic attack, angina pectoris,
rheumatoid arthritis, or sleep apnea. Previous research has shown that depression is often
associated with inflammatory problems, but the directional relationship involved is still
unclear. A recent meta-analysis of prospective studies analyzing the depression-diabetes
relationship determined that depression was associated with a 60% increased risk of type
2 diabetes (Mezuk, Eaton, Albrecht, & Golden, 2008), suggesting that there is a strong
and robust relationship between these two conditions. High rates of depression have also
been found among people with obstructive sleep apnea (Harris, Glozier, Ratnavadivel, &
Grunstein, 2009), and a recent longitudinal study determined that major depression at
baseline was associated with several long-term medical conditions, including heart
disease, arthritis, asthma, bronchitis, hypertension and migraines (Patten et ah, 2008).
Changes in cytokine levels may be responsible for depression related diseases that are
associated with an elevated inflammatory response (Howren et ah, 2009). However,
further analysis is still needed before depression can be considered a primary risk factor
for many inflammatory conditions.
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In conclusion, BMI was associated with increased concentrations of CRP, IL-6
and elevated depression scores while females demonstrated higher CRP levels and
depression scores compared to males among this SDA population. Therefore, gender as
well as weight status may serve as important risk factors for health problems associated
with depression and elevated inflammation. However, despite the fact that depression
has been directly associated with inflammation based on previous research, no
relationship was found in the current study. This null finding may be due to the use of
self-reported depression measurement based on CESD scores. Nevertheless, future
studies should consider the psychological as well as physical health status of research
participants when assessing their level of inflammation since they both have been shown
to effect cytokine levels.
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Table 7. Regression analysis models illustrating the association between various predictor variables and Depression
Predictor Variables
Ethnicity
Blacks vs Whites

(3

Model 1
B (SE) P-value

P

Model 3
B (SE) P-value

p

Model 4
B (SE) P-value

P

Model 5
B (SE) P-value

-0.619
(0.888)

0.486

-0.057

-1.019
(0.890)

0.253

-0.085

-1.517
(0.900)

0.093

-0.099

-1.766
(0.895)

0.053

Age

-0.039

-0.028
(0.036)

0.426

-0.038

-0.028
(0.036)

0.440

-0.027

-0.020
(0.036)

0.582

-0.064

-0.047
(0.036)

0.199

Gender
Females vs Males

0.153

2.660
(0.835)

0.002

0.154

2.689
(0.836)

0.001

0.159

2.762
(0.829)

0.001

0.170

2.966
(0.824)

0.000

Education

-0.066

-0.866
(0.645)

0.180

-0.032

-0.417
(0.655)

0.524

-0.031

-0.404
(0.650)

0.534

-0.022

-0.285
(0.645)

0.658

0.207

1.976
(0.452)

0.000

0.204

1.945
(0.448)

0.000

0.198

1.892
(0.445)

0.000

0.192

1.828
(0.441)

0.000

Frequency of vigorous
activities per week

-0.060

-0.217
(0.172)

0.209

-0.039

-0.141
(0.173)

0.414

-0.027

-0.096
(0.172)

0.575

Vegetarian diet
Vegetarian vs NonVegetarian
Body Mass Index

-0.133

-2.293
(0.825)

0.006

-0.108

-1.853
(0.833)

0.027

-0.089

-1.537
(0.832)

0.065

0.139

0.227
(0.080)

0.005

0.106

0.173
(0.082)

0.034

2.880
(0.944)

0.002

0.539
(0.857)

Difficulty meeting family
expenses in the last year

^

Model 2
B (SE) P-value

-0.035

0.030

Inflammatory Condition
Diagnosis
Diagnosis vs No
Diagnosis
R1 Change

0.530

p

0.150

0.001

0.083

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.021

0.017

0.019

Table 8. Regression analysis models illustrating the association between depression and CRP after controlling for
various predictor variables
Predictor Variables

Model 1
B (SE) P-value

(3

Model 2
B (SE) P-value

p

Model 3
B (SE)
P-value

P

Model 4
B (SE) P-value

p

Model 5
B (SE) P-value

0.037

0.002
(0.003)

0.457

0.003

0.000
(0.003)

0.947

-0.043

-0.003
(0.003)

0.363

-0.046

-0.003
(0.003)

0.334

Ethnicity
Blacks vs Whites

0.098

0.111
(0.058)

0.056

0.064

0.072
(0.057)

0.211

-0.005

-0.006
(0.055)

0.914

-0.008

-0.009
(0.056)

0.879

Age

0.113

0.005
(0.002)

0.025

0.107

0.005
(0.002)

0.034

0.130

0.006
(0.002)

0.007

0.124

0.006
(0.002)

0.012

Gender
Females vs Males

0.172

0.189
(0.055)

0.001

0.175

0.192
(0.054)

0.000

0.194

0.213
(0.051)

0.000

0.196

0.216
(0.052)

0.000

Education

-0.050

-0.041
(0.042)

0.334

0.003

0.003
(0.043)

0.949

0.010

0.008
(0.040)

0.842

0.011

0.009
(0.040)

0.823

0.013

0.008
(0.030)

0.788

0.017

0.010
(0.029)

0.812

0.015

0.009
(0.028)

0.753

0.014

0.009
(0.028)

0.757

-0.104

-0.024
(0.011)

0.033

-0.058

-0.013
(0.011)

0.211

-0.056

-0.013
(0.011)

0.230

-0.188

-0.204
(0.054)

0.000

-0.133

-0.145
(0.051)

0.005

-0.131

-0.142
(0.052)

0.006

0.341

0.036
(0.005)

0.000

0.337

0.035
(0.005)

0.000

0.023

0.028
(0.059)

0.638

Depression

oo
o

p
0.073

0.005
(0.003)

Difficulty meeting
family expenses in the
last year
Frequency of vigorous
activities per week

0.131

Vegetarian diet
Vegetarian vs NonVegetarian
Body Mass Index
Inflammatory Condition
Diagnosis
Diagnosis vs No
Diagnosis
R1 Change

0.005

0.053

0.043

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.099

0.000

Table 9. Regression analysis models illustrating the association between depression and IL-6 after controlling for
various predictor variables

oo

Predictor Variables

P

Depression

0.051

Model 1
B (SE) P-value

p

Model 2
B (SE)
P-value

p

Model 3
B (SE) P-value

p

Model 4
B (SE) P-value

p

Model 5
B (SE)
P-value

0.060

0.003
(0.003)

0.233

0.046

0.002
(0.003)

0.355

0.027

0.001
(0.003)

0.596

0.023

0.001
(0.003)

0.645

Ethnicity
Blacks vs Whites

0.168

0.157
(0.048)

0.001

0.156

0.146
(0.048)

0.003

0.127

0.118
(0.049)

0.016

0.124

0.116
(0.049)

0.019

Age

0.176

0.007
(0.002)

0.001

0.157

0.006
(0.002)

0.002

0.167

0.006
(0.002)

0.001

0.161

0.006
(0.002)

0.002

Gender
Females vs Males

-0.017

-0.016
(0.046)

0.729

-0.028

-0.025
(0.046)

0.580

-0.020

-0.018
(0.045)

0.696

-0.017

-0.016
(0.046)

0.734

Education

-0.068

-0.046
(0.035)

0.190

-0.045

-0.031
(0.036)

0.388

-0.043

-0.029
(0.036)

0.413

-0.041

-0.028
(0.036)

0.428

-0.025
(0.025)

0.317

-0.051

-0.025
(0.025)

0.309

-0.052

-0.026
(0.025)

0.296

-0.052

-0.026
(0.025)

0.294

-0.115

-0.022
(0.009)

0.021

-0.095

-0.018
(0.009)

0.055

-0.093

-0.018
(0.009)

0.062

-0.029

-0.026
(0.045)

0.559

-0.006

-0.005
(0.045)

0.908

-0.003

-0.003
(0.046)

0.949

0.147

0.013
(0.004)

0.004

0.142

0.012
(0.005)

0.007

0.024

0.024
(0.052)

0.650

0.003
(0.003)

0.294

-0.050

Difficulty meeting
family expenses in tire
last year
Frequency of vigorous
activities per week
Vegetarian diet
Vegetarian vs NonVegetarian
Body Mass Index
Inflammatory Condition
Diagnosis
Diagnosis vs No
Diagnosis
R1 Change

0.003

0.048

0.013

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.018

0.000

Table 10. Regression analysis models illustrating the association between depression and IL-10 after controlling for
various predictor variables
Predictor Variables

Model 1
B (SE) P-value

P

Model 2
P-value
B (SE)

p

Model 3
B (SE) P-value

p

Model 4
B (SE) P-value

p

Model 5
B (SE) P-value

0.061

0.005
(0.004)

0.244

0.063

0.005
(0.004)

0.234

0.052

0.004
(0.004)

0.329

0.057

0.005
(0.005)

0.290

Ethnicity
Blacks vs Whites

0.037

0.054
(0.081)

0.501

0.032

0.047
(0.081)

0.563

0.017

0.025
(0.083)

0.758

0.020

0.030
(0.083)

0.718

Age

-0.021

-0.001
(0.003)

0.692

0.014

0.001
(0.003)

0.803

0.019

0.001
(0.003)

0.732

0.026

0.002
(0.003)

0.637

Gender
Females vs Males

0.001

0.002
(0.077)

0.983

0.028

0.041
(0.077)

0.599

0.034

0.050
(0.078)

0.521

0.030

0.044
(0.078)

0.576

Education

-0.024

-0.026
(0.059)

0.657

-0.022

-0.024
(0.060)

0.686

-0.020

-0.022
(0.060)

0.719

-0.022

-0.023
(0.060)

0.697

-0.046
(0.042)

0.273

-0.053

-0.043
(0.042)

0.307

-0.052

-0.042
(0.042)

0.318

-0.051

-0.041
(0.042)

0.331

0.141

0.043
(0.016)

0.008

0.150

0.045
(0.016)

0.005

0.147

0.044
(0.016)

0.006

-0.094

-0.136
(0.076)

0.076

-0.086

-0.123
(0.077)

0.109

-0.090

-0.129
(0.077)

0.097

0.065

0.009
(0.008)

0.234

0.072

0.010
(0.008)

0.199

-0.033

-0.052
(0.089)

0.559

Depression

oo
to

P
0.056

0.005
(0.004)

0.266

-0.058

Difficulty meeting
family expenses in the
last year
Frequency of vigorous
activities per week
Vegetarian diet
Vegetarian vs
Non-Vegetarian
Body Mass Index
Inflammatory Condition
Diagnosis
Diagnosis vs No
Diagnosis
R2 Change

0.003

0.006

0.025

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.004

0.001

Table 11. Regression analysis models illustrating the association between depression and TNF-ot after controlling for
various predictor variables
Predictor Variables

Model 1
B (SE) P-value

P

Model 2
B (SE) P-value

P

Model 3
B (SE) P-value

p

Model 4
B (SE) P-value

p

Model 5
B (SE) P-value

-0.031

-0.007
(0.012)

0.555

-0.034 -0.008
(0.013)

0.527

-0.038

-0.009
(0.013)

0.478

-0.036

-0.008
(0.013)

0.518

Ethnicity
Blacks vs Whites

-0.003

-0.014
(0.227)

0.950

-0.006 -0.025
(0.230)

0.913

-0.012

-0.052
(0.236)

0.827

-0.011

-0.044
(0.238)

0.852

Age

-0.013

-0.002
(0.009)

0.801

-0.015

-0.003
(0.009)

0.787

-0.013

-0.002
(0.009)

0.819

-0.008

-0.001
(0.010)

0.885

Gender
Females vs Males

-0.085

-0.349
(0.217)

0.108

-0.086 -0.351
(0.220)

0.112

-0.083

-0.340
(0.221)

0.126

-0.085

-0.349
(0.224)

0.119

Education

0.025

0.076
(0.166)

0.646

0.030

0.090
(0.171)

0.598

0.031

0.094
(0.171)

0.585

0.030

0.091
(0.172)

0.598

Difficulty meeting
family expenses in the
last year
Frequency of vigorous
activities per week

-0.010

-0.022
(0.119)

0.851

-0.010 -0.022
(0.119)

0.857

-0.009

-0.020
(0.120)

0.865

-0.008

-0.019
(0.120)

0.875

-0.012

-0.010
(0.045)

0.817

-0.008

-0.007
(0.046)

0.878

-0.010

-0.008
(0.046)

0.854

-0.013

-0.053
(0.217)

0.806

-0.009

-0.038
(0.219)

0.861

-0.012

-0.047
(0.221)

0.832

0.029

0.011
(0.022)

0.604

0.033

0.013
(0.022)

0.566

-0.018

-0.082
(0.254)

0.748

Depression

oc

P
-0.051

-0.012
(0.012)

0.315

Vegetarian diet
Vegetarian vs NonVegetarian
Body Mass Index
Inflammatory Condition
Diagnosis
Diagnosis vs No
Diagnosis
7?2 Change

0.001

0.012

0.000

P = standardized regression coefficient, B = unstandardized regression coefficient, SE = standard error

0.004

0.000

CHAPTER 6
CONCLUSIONS
A. Summary and Findings
The results of the present study have shown that a number of factors can affect
inflammation which may be associated with chronic health problems. For instance,
inflammation was found to vary according to age, gender, and ethnicity. In particular,
higher levels of pro-inflammatory cytokines were exhibited among Blacks and female
participants compared to Whites and male participants. The Blacks and the female SDAs
may therefore be at an increased risk for future cardiovascular disease and other
inflammatory health problems. Increased age was also associated with an elevated proinflammatory response, which has been associated with many detrimental effects that
contribute to frailty and disability among elderly populations (Hunt, Walsh, Voegeli, &
Roberts, 2010b). However, healthy lifestyle practices may counteract these effects, and
function as important determinants of quality of life as individuals get older.
Lifestyle factors played an important role in the level of inflammation among the
population of SDAs from the current study, as increased exercise frequency and the
consumption of a vegetarian diet were found to have anti-inflammatory effects.
Practicing these behaviors may prove to have other important health benefits as well.
which should be further assessed through interventional studies to determine if they have
a dose-response effect on inflammation and other physiological factors. The positive
association between increased body mass and elevated levels of CRP and IL-6 has been
illustrated in previous studies (Berg & Scherer, 2005; Nicklas et ah, 2004; Panagiotakos
et ah, 2005), and was further verified in the present investigation. On the other hand, the
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association between BMI and anti-inflammatory cytokines has not been fully determined.
The present study showed no significant association between BMI and IL-10, so it is
possible that this cytokine is not directly stimulated by elevated body mass. However,
further analysis on this particular relationship is still needed. Finally, factors related to
SES were not significantly associated with inflammation levels, but low SES has been
associated with increased inflammation based on previous research (Gruenewald, Cohen,
Matthews, Tracy, & Seeman, 2009; Koster, Bosma, Penninx, Newman, Harris, van Eijk,
Kempen, Simonsick, Johnson, Rooks, Ayonayon, Rubin, & Kritchevsky, 2006; K. L.
Petersen et al., 2008). Many of the SDAs in the current population achieved high levels
of education and reported no significant difficulties meeting family expenses for basic
needs in the last year, so they may not have been prone to elevated inflammation based
on their socioeconomic background.
B. Limitations
The original objective of this study was to assess the effects of obesity and
depression on both pro-inflammatory and anti-inflammatory markers as well as determine
whether there were ethnic and gender specific differences in inflammation. Yet the
results showed that this population of SDAs did not have high scores of depression, and
there were no significant associations between depression and the markers of
inflammation. It was therefore necessary to examine other possible determinants of
inflammation among SDAs to assess their overall risk for inflammatory based health
problems. SDAs have lower mortality rates and report better physical and mental health
than the general population (J. W. Lee et al., 2009). However, factors related to SES and
overall lifestyle practice may play an important role in determining the quality of life of
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current SDAs. Therefore, education level, degree of difficulty meeting family expenses
for basic needs, exercise frequency, and vegetarian diet consumption were examined
through regression analysis to determine if these factors were associated with
inflammation in this population.
There was no significant interactive effect of obesity (based on BMI) and
depression on the inflammatory marker concentrations from the regression analysis (data
not shown). Although a significant interactive effect of BMI and depressive symptoms
on CRP concentrations has been reported previously, the results were based on a large
population of German males which suggests that the effect may have been gender and
population specific (K. H. Ladwig et ah, 2003). The inflammatory effects of obesity and
depression may therefore function independently among SDAs, possibly involving
distinct cytokine pathways.
C. Areas for Future Research
The current investigation may serve as an important pilot study for future analysis
of inflammatory determinants among distinct populations. Because this was a crosssectional study, the directional relationship between the predictor variables and the
inflammatory markers could not be determined. However, the effect of healthy lifestyle
practices such as a vegetarian or high fiber diet as well as increased physical activity on
inflammation levels should be investigated. Study participants should be randomly
assigned to a control and treatment group, and matched according to demographic (age,
gender, and ethnicity) and socioeconomic status. Because there are a number of factors
that can lead to elevated inflammation, it will be important to control for certain variables
such as smoking status, alcohol consumption, and previous history of inflammatory
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conditions. The goal of this type of intervention would be to determine the optimal
method for reducing inflammation and chronic disease risk among healthy individuals.
In addition to pro-and anti-inflammatory cytokines, future studies should also
analyze the ratio of pro-inflammatory to anti-inflammatory cytokines among participants.
Many diseases are associated with an imbalance of inflammatory cytokines, so this
analysis would help to determine people’s risk for different inflammatory conditions in a
more specific way. In the present study, we did analyze the ratio of TNF-a to IL-10
among the SDA population, but the TNF-a concentration was below the detection limit
for many of the participants which prevented the ratio values from being accurately
determined. Genetic markers of inflammation should also be examined to check for
possible hereditary differences in pro-inflammatory and anti-inflammatory cytokine
levels. Finally, since ethnic differences in inflammation were found in the present
investigation, a cohort of participants from different racial backgrounds should be
assessed in future studies to determine the effectiveness of lifestyle interventions on
reducing inflammation among these ethnic groups.
D. Implications for Preventive Care
The more data that can be obtained about inflammation and its effects on the
body, the better equipped we will be in dealing with many health problems. Although
there is much about the immune system that is still unknown, new information is
constantly being discovered that may be useful in trying to maintain a healthy
inflammatory balance for many individuals. The key is to better understand the signaling
pathways by which circulating levels of inflammatory markers impact the pathobiology
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of common diseases. This level of information may help in finding effective techniques
and interventions for improving the quality of life as people age.
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Appendix A
IL-10 ELISA Protocol
1. Prepare 6 standards, one for each standard curve point: 600, 240, 96, 38.4, 15.36,
and 0 pg/ml. Use a 1:2.5 serial dilution for the standard curve as follows:
a. Pipette 240 pi of appropriate diluent into each tube.
b. Pipette 160 pi of the reconstituted standard into the first tube (600 pg/ml)
and mix
c. Pipette 160 pi of the this dilution into the second tube labeled (240 pg/ml)
and mix
d. Repeat the serial dilutions (using 160 pi) three more times to complete the
standard curve points
2. Add 50 pi of reconstituted standards or test samples in duplicate to each well.
3. Add 50 pi of Biotinylated Antibody Reagent to all wells containing standards or
samples.
4. Carefully cover plate with an adhesive plate cover. Ensure all edges and strips are
tightly sealed by running your thumb over edges and down each strip. Incubate
for two hours at room temperature, 20-25°C.
5. Empty plate contents. Use a squirt bottle to vigorously fill each well completely
with Wash Buffer, then empty plate contents. Repeat procedure two additional
times for a total of three washes. Blot plate onto paper towels or other absorbent
material.
6. For one complete 96-well plate, add 30 pi of Streptavidin-HRP Concentrate to 12
ml of Streptavidin-HRP Dilution Buffer and mix gently.
7. Add 100 pi of prepared Streptavidin-HRP Solution to each well.
8. Carefully attach a new adhesive plate cover, ensuring all edges and strips are
tightly sealed. Incubate plate for 30 minutes at room temperature, 20-25°C.
9. Carefully remove the plate cover and discard plate contents. Wash plate as
described in step 5.
10. Pipette 100 pi of TMB Substrate Solution into each well.
11. Allow enzymatic color reaction to develop at room temperature in the dark for 45
minutes. Do not cover plate with aluminum foil or a plate sealer.
12. After 30 minutes, stop the reaction by adding 100 pi of Stop Solution to each
well.
13. Measure absorbance on an ELISA plate reader set at 450 nm and 550 nm.
Subtract 550 nm values from 450 nm values to correct for optical imperfections in
the microplate.
14. Use the standard curve to determine IL-10 amount in an unknown sample.
Generate the standard curve by plotting the average absorbance obtained for each
standard concentration on the vertical (Y) axis vs. the corresponding IL-10
concentration (pg/ml) on the horizontal (X) axis.
15. The amount of IL-10 in each sample is determined by interpolating from the
absorbance value (Y axis) to the IL-10 concentration (X axis) using the standard
curve.
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Appendix B
1.

2.
3.
4.

5.

6.
7.

8.
9.
10.
11.
12.
13.
14.
15.

16.

17.

TNF-a ELISA Protocol
Prepare 7 standards, one for each standard curve point: 1000, 500, 250, 125, 62.5,
31.2, 15.6 and 0 pg/ml. Use a 1:2 serial dilution to generate the standard curve
points as follows:
a. Pipette 200 pi of Sample Diluent into each tube.
b. Pipette 200 pi of the reconstituted Standard into the first tube (1,000
pg/ml) and mix.
c. Pipette 200 pi of this dilution into the next tube (500 pg/ml) and mix.
d. Repeat serial dilutions (using 200 pi) five more times to complete the
standard curve points.
Add 50 pi Sample Diluent to each well.
Add 50 pi standard or sample to each well in duplicate.
Carefully cover plate with an adhesive plate cover. Ensure that all edges and strips
are sealed tightly by running your thumb over the edges and down each strip.
Incubate for one hour at room temperature, 20-25°C.
Empty plate contents. Use a squirt bottle to vigorously fill each well completely
with Wash Buffer, then empty plate contents. Repeat procedure two additional
times for a total of three washes. Blot plate onto paper towels or other absorbent
material.
Add 100 pi of the Biotinylated Antibody Reagent to each well.
Carefully cover plate with an adhesive plate cover. Ensure all edges and strips are
tightly sealed by running your thumb over the edges and down each strip.
Incubate for one hour at room temperature, 20-25°C.
Carefully remove the adhesive plate cover. Wash plate as described in step 5.
Add 100 pi of Streptavidin-HRP Reagent to each well.
Carefully attach a new adhesive plate cover, ensuring all edges and strips are
tightly sealed. Incubate plate for 30 minutes at room temperature, 20-25°C.
Carefully remove the adhesive cover and discard plate contents. Wash plate as
described in step 5.
Pipette 100 pi of TMB Substrate Solution into each well.
Allow enzymatic reaction to develop at room temperature in the dark for 30
minutes. Do not cover plate with aluminum foil or a plate sealer.
After 30 minutes, stop the reaction by adding 100 pi of Stop Solution to each
well.
Measure absorbance on an ELISA plate reader set at 450 nm and 550 nm.
Subtract 550 nm values from 450 nm values to correct for optical imperfections in
the microplate.
Generate the standard curve by plotting the average absorbance (450 nm minus
550 nm) obtained for each standard concentration on the vertical (Y) axis vs. the
corresponding TNFa concentration on the horizontal (X) axis.
The amount of TNFa in each sample is determined by interpolating from the
absorbance value (Y axis) to the TNFa concentration (X axis) using the standard
curve.
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Documentation of IRB approval for BioMRS

INSTITUTIONAL REVIEW BOARD
Extension Requested - Approval Notice (Expedited)

IRB# 55243

OmCS OF SPONSORED RESEARCH 'ttW AnUmon Stmi ■ Lem !Ms, CA SOSO
{$09} SS8-4&V {wkx}'{909}5BM$t m

To:

Fraser, Gary E,

Department:

Epidemiology & Biostatistics
Biological and psychosocial manifestations of religion

Protocol:

Your request to extend the protocol indicated above has been reviewed administratively.
Extension Request:
Risk to research subjects:
Approval period begins
Stipulations of approval are:

Approved
Minimal
OI-Jun-2009 and ends 31-May-2010
Waiver of documentation of informed consent for Adventist
Religion & Health Survey, per 46.117(c)(1)

Consent Form
It this study was approved on the condition that a consent form is required AND subjects are still being
enrolled, only the consent form bearing the IRR authorization stamp can be used. This will become your
OFFICIAL consent form for the dates specified and should be used as the new master for making copies
to give prospective subjects.
0

Master consent, form with up-dated authorized stamp is enclosed.

\y/ Updated consent form not required. Approval limited to data analysis or follow-up of currently
enrolled subjects only.
D

Not applicable: IRB approved a waiver of informed consent, as noted above.

IRB Communications
Please continue to notify the IRB in writing of any modifications or adverse events relating to the
approved research protocol. Your assistance in providing the Pi's name and the protocol's IRS # on al!
communications with the IRB about this project will expedite necessary communications.
Thank you for your cooperation in LLU's shared responsibility for the ethical use ol human subjects in
research.

Signature of iRB Chair/Designee:.

FI

U»» Umsa University Adventist
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tenia Linda University Children's Hospital, LIU Cormnutty Medical Center), Lome Unde University Behavioral Medtofce. and affiliated medical pramkm groups.
iRB Chair:
IRB Administrator:
IRB Specialist:
Rhodes L Rigsby, M.P.
Unde G. Halstead, M.A., Director
Mam Testerman
Department of Medicine
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Office of Sponsored Fimeatch
(303} 558-2341, rnQsby@Hu.itau
Ex! 43579, Fax 80!3i, /fta/sreao^fe.edU
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